Query psy10618
Match_columns 339
No_of_seqs 229 out of 273
Neff 4.2
Searched_HMMs 46136
Date Fri Aug 16 22:55:59 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy10618.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/10618hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG1930|consensus 100.0 3.6E-81 7.9E-86 614.8 13.0 233 37-314 223-456 (483)
2 cd01213 tensin Tensin Phosphot 100.0 2.7E-40 5.8E-45 287.1 5.8 117 192-314 1-117 (138)
3 PF05826 Phospholip_A2_2: Phos 100.0 1E-35 2.3E-40 245.3 0.0 54 64-117 1-54 (99)
4 cd04704 PLA2_bee_venom_like PL 100.0 3.5E-34 7.6E-39 235.7 4.0 50 63-112 1-50 (97)
5 PF08416 PTB: Phosphotyrosine- 99.9 5.8E-26 1.3E-30 195.0 4.2 98 198-310 1-100 (131)
6 cd01212 JIP JNK-interacting pr 99.4 1.7E-13 3.7E-18 120.6 7.2 111 199-315 5-128 (148)
7 cd04705 PLA2_group_III_like PL 99.2 1.8E-12 4E-17 107.9 1.5 55 81-144 26-80 (100)
8 cd00934 PTB Phosphotyrosine-bi 99.2 5.7E-11 1.2E-15 96.8 7.1 80 197-277 2-83 (123)
9 smart00462 PTB Phosphotyrosine 99.1 1.5E-10 3.3E-15 96.2 7.3 82 195-277 2-85 (134)
10 cd01267 CED6_AIDA1b Phosphotyr 99.1 1.5E-10 3.2E-15 98.6 7.3 79 199-278 4-87 (132)
11 cd00618 PLA2_like PLA2_like: P 98.9 9.2E-10 2E-14 86.5 2.5 46 65-112 1-46 (83)
12 cd01273 CED-6 CED-6 Phosphotyr 98.7 6.5E-08 1.4E-12 84.1 7.9 88 191-279 3-98 (142)
13 cd01268 Numb Numb Phosphotyros 98.5 3.8E-07 8.2E-12 80.1 7.0 116 192-315 8-128 (138)
14 PF00640 PID: Phosphotyrosine 98.4 3.1E-07 6.7E-12 76.6 5.8 77 200-277 2-94 (140)
15 cd01216 Fe65 Fe65 Phosphotyros 98.4 8.1E-07 1.8E-11 76.1 7.2 76 199-275 4-79 (123)
16 cd04705 PLA2_group_III_like PL 98.3 1.8E-07 3.9E-12 78.3 1.2 35 283-317 61-100 (100)
17 cd01274 AIDA-1b AIDA-1b Phosph 98.3 1.5E-06 3.2E-11 74.9 6.4 80 199-279 4-84 (127)
18 cd01214 CG8312 CG8312 Phosphot 98.3 7.7E-07 1.7E-11 77.9 4.3 83 198-285 3-87 (133)
19 PF14719 PID_2: Phosphotyrosin 98.3 1E-06 2.2E-11 80.6 5.2 82 199-285 2-84 (182)
20 smart00085 PA2c Phospholipase 98.2 9.5E-07 2.1E-11 75.2 2.2 45 62-111 17-61 (117)
21 cd01215 Dab Disabled (Dab) Pho 97.6 0.00015 3.2E-09 64.1 6.6 85 193-278 9-95 (139)
22 cd01271 Fe65_C Fe65 C-terminal 97.4 0.00039 8.5E-09 60.4 6.3 73 199-273 4-78 (124)
23 cd01270 DYC-1 DYC-1 (DYB-1 bin 97.2 0.00082 1.8E-08 59.5 6.5 83 196-279 2-98 (140)
24 KOG3775|consensus 96.9 0.00067 1.5E-08 68.6 3.0 113 198-314 338-461 (482)
25 cd04706 PLA2_plant PLA2_plant: 96.8 0.00083 1.8E-08 57.9 2.4 35 67-103 24-58 (117)
26 cd01209 SHC SHC phosphotyrosin 96.2 0.018 3.9E-07 52.2 7.5 90 189-279 3-119 (160)
27 cd00173 SH2 Src homology 2 dom 94.8 0.012 2.6E-07 45.8 1.0 47 123-171 45-93 (94)
28 cd04707 otoconin_90 otoconin_9 93.6 0.025 5.4E-07 48.8 0.6 30 69-104 22-51 (117)
29 cd00125 PLA2c PLA2c: Phospholi 93.2 0.029 6.3E-07 48.1 0.4 31 69-105 25-55 (115)
30 PF08398 Parvo_coat_N: Parvovi 93.0 0.045 9.6E-07 42.9 1.2 48 65-115 1-49 (64)
31 KOG3537|consensus 92.6 0.23 4.9E-06 51.7 5.8 118 199-322 39-177 (543)
32 cd01208 X11 X11 Phosphotyrosin 92.5 0.44 9.5E-06 43.2 6.8 78 196-275 4-88 (156)
33 cd01217 CG12581 CG12581 Phosph 91.1 0.5 1.1E-05 42.8 5.7 74 198-271 3-80 (158)
34 cd01211 GAPCenA GAPCenA Phosph 90.7 0.75 1.6E-05 40.4 6.2 89 200-291 5-96 (125)
35 KOG4087|consensus 79.1 0.77 1.7E-05 41.2 0.6 30 69-104 46-75 (144)
36 KOG3536|consensus 76.7 2.4 5.1E-05 42.4 3.2 93 184-277 33-131 (321)
37 smart00252 SH2 Src homology 2 76.6 0.91 2E-05 34.9 0.3 37 123-162 46-83 (84)
38 PF00068 Phospholip_A2_1: Phos 75.8 0.57 1.2E-05 39.8 -1.1 31 69-105 26-56 (116)
39 cd01269 PLX Pollux (PLX) Phosp 70.5 12 0.00027 33.1 5.8 77 199-276 4-83 (129)
40 PF00017 SH2: SH2 domain; Int 69.2 1.3 2.9E-05 33.5 -0.4 32 123-157 45-77 (77)
41 cd00618 PLA2_like PLA2_like: P 67.9 2.4 5.2E-05 33.1 0.8 18 285-302 65-82 (83)
42 smart00085 PA2c Phospholipase 58.4 2 4.4E-05 36.7 -1.2 45 285-332 63-107 (117)
43 PF00357 Integrin_alpha: Integ 53.6 2.1 4.7E-05 24.9 -1.3 8 256-263 4-11 (15)
44 KOG4448|consensus 52.8 12 0.00025 38.1 2.8 93 198-295 62-162 (374)
45 PF10480 ICAP-1_inte_bdg: Beta 50.1 87 0.0019 29.7 7.8 70 197-267 61-139 (200)
46 PF11663 Toxin_YhaV: Toxin wit 42.8 36 0.00078 30.6 4.0 77 216-305 40-127 (140)
47 PF02576 DUF150: Uncharacteris 38.4 26 0.00056 30.3 2.5 43 216-264 43-85 (141)
48 cd04706 PLA2_plant PLA2_plant: 34.3 18 0.00039 31.5 0.8 21 286-306 61-81 (117)
49 cd07158 NR_DBD_Ppar_like The D 32.4 22 0.00047 27.7 0.9 15 251-265 19-33 (73)
50 PRK14630 hypothetical protein; 29.5 46 0.00099 29.5 2.6 41 216-264 55-95 (143)
51 PF13786 DUF4179: Domain of un 29.2 49 0.0011 25.9 2.5 17 233-249 57-73 (94)
52 PRK14634 hypothetical protein; 25.5 66 0.0014 28.8 2.9 43 216-264 56-98 (155)
53 PRK14647 hypothetical protein; 25.4 63 0.0014 28.9 2.8 43 216-264 55-97 (159)
54 PF00712 DNA_pol3_beta: DNA po 24.8 91 0.002 25.8 3.4 72 217-305 13-84 (120)
55 KOG0197|consensus 24.7 24 0.00053 37.2 -0.0 52 122-173 133-184 (468)
56 cd07157 2DBD_NR_DBD1 The first 24.5 47 0.001 26.9 1.6 16 250-265 20-35 (86)
57 cd07166 NR_DBD_REV_ERB DNA-bin 24.1 36 0.00077 27.8 0.8 46 251-302 24-70 (89)
58 cd06960 NR_DBD_HNF4A DNA-bindi 24.1 54 0.0012 25.7 1.8 47 250-302 18-64 (76)
59 KOG4278|consensus 23.6 26 0.00056 39.2 -0.1 49 122-172 196-244 (1157)
60 cd06916 NR_DBD_like DNA-bindin 23.5 52 0.0011 25.6 1.6 47 250-302 18-64 (72)
61 cd06965 NR_DBD_Ppar DNA-bindin 22.0 46 0.00099 26.8 1.1 41 250-302 19-64 (84)
62 PRK14645 hypothetical protein; 21.0 94 0.002 27.9 3.0 43 216-264 58-100 (154)
63 cd07168 NR_DBD_DHR4_like DNA-b 21.0 45 0.00097 27.3 0.8 56 235-302 17-72 (90)
64 PRK14643 hypothetical protein; 20.4 91 0.002 28.3 2.8 43 216-264 60-102 (164)
65 TIGR03330 SAM_DCase_Bsu S-aden 20.4 1.1E+02 0.0024 25.9 3.1 46 204-249 11-56 (112)
66 PRK14640 hypothetical protein; 20.3 97 0.0021 27.6 2.9 43 216-264 53-95 (152)
67 PF02675 AdoMet_dc: S-adenosyl 20.1 77 0.0017 26.1 2.1 46 204-249 6-51 (106)
No 1
>KOG1930|consensus
Probab=100.00 E-value=3.6e-81 Score=614.79 Aligned_cols=233 Identities=49% Similarity=0.813 Sum_probs=208.5
Q ss_pred hhhhhhccCCCCCCcccccccccccccccCCccccCCCCCCCCccCCCCccccchhhccccCCccccccCcccccccCCC
Q psy10618 37 FAVRSVKDKRPNPQITQTTSAYPLFNGIIPGTKWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIRAHTNRYNITNDS 116 (339)
Q Consensus 37 ~~~~~~~d~~~~~~~~~~~~~~~~~~~i~PGTkWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~~~~~kygLtN~s 116 (339)
-++.+++|++|+.++.+++..++.. +|.+.++- .=|..+.++.
T Consensus 223 QAIalLrdkePGtFvvRDS~SfrGa---------------------yGLAlKVs-------tPPPs~~~~~--------- 265 (483)
T KOG1930|consen 223 QAIALLRDKEPGTFVVRDSHSFRGA---------------------YGLALKVS-------TPPPSVQPGD--------- 265 (483)
T ss_pred HHHHHhhcCCCCeEEEecCCcCCCc---------------------cceEEEec-------cCCCcccCCC---------
Confidence 3566788999999988887776533 45777776 4555555543
Q ss_pred CcchhhhhhhhccccCCCCceeccCCCCCCCCchhhheeccccccccccccccCCCCCCCCCCCCCCCCCchHHHHHhhc
Q psy10618 117 MYTNNELVRHFLIEPTPRGVRLKGCSNEPVFSSLSALVYQHSVLPLALPCRLSLPDSEPSLPPDAVSPSITSAQLLLAQG 196 (339)
Q Consensus 117 gyT~~~lvrHfLIe~~~~gv~lkGc~~Ep~F~Slsalv~qhsi~~laLPC~L~iP~~d~~~~~~~~~~~~~~~~~ll~~g 196 (339)
+...+|||||||||++++||+||||+|||||+||||||+||||++|||||+|+||++|+.+ +......++++++||+||
T Consensus 266 g~~~neLVRHFLIE~spkGVkLKGC~nEP~FGSLSALV~QHSIt~LALPckL~iP~rDp~e-e~~~~~~~~a~a~LLkqG 344 (483)
T KOG1930|consen 266 GSDSNELVRHFLIEPSPKGVKLKGCDNEPVFGSLSALVYQHSITALALPCKLVIPDRDPLE-EAPVPEHTSATAALLKQG 344 (483)
T ss_pred CCchhhhhhhheeccCCCceeccCCCCCCccchhHHHHhhccchhhhcceeEeccCCCccc-CCCCCCCchhHHHHHhhC
Confidence 2334899999999999999999999999999999999999999999999999999999965 445667889999999999
Q ss_pred cccceeeeeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCCC
Q psy10618 197 AACNVLYLVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPEDS 276 (339)
Q Consensus 197 aaCnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~dR 276 (339)
||||||||+|||||+|||++||+||++.++..+|.|.+|+||||||+|||||||||||||||||||+|+|+|||||||||
T Consensus 345 AACnVlyl~SVd~ESLTG~~av~kAt~~~~~~~p~p~~tvVHFKVSsQGITLTDNqRK~FFRRHypv~sv~Fc~mDPq~R 424 (483)
T KOG1930|consen 345 AACNVLYLGSVDVESLTGNEAVQKATSSQRAINPTPRATVVHFKVSSQGITLTDNQRKVFFRRHYPVNSVIFCGMDPQER 424 (483)
T ss_pred ccceEEEEeeeeccccccHHHHHHHHHHHhhcCCCCCceEEEEEEeccceeeeccchhhheecccccceeEEecCChHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccc-chhHHHHhcCCCChhhhhccee
Q psy10618 277 RCLTRPWCISKSHCSC-DKNFKSCLKSTKSAAADVMGEF 314 (339)
Q Consensus 277 rW~~~~~~~~~s~C~c-d~~F~~CLk~~~~~~sn~vG~~ 314 (339)
||++.| |.- .++|+|++|+++.+.+|+||+|
T Consensus 425 ~w~~~g-------~~~~s~iFgFVAr~~gS~teN~CHlF 456 (483)
T KOG1930|consen 425 RWTNTG-------CGAQSKIFGFVARKPGSSTENVCHLF 456 (483)
T ss_pred ccccCC-------CCCcceEEEEEeccCCCCcccceeee
Confidence 999963 333 6899999999999999999987
No 2
>cd01213 tensin Tensin Phosphotyrosine-binding (PTB) domain. Tensin Phosphotyrosine-binding (PTB) domain. Tensin is a a focal adhesion protein, which contains a C-terminal SH2 domain followed by a PTB domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=100.00 E-value=2.7e-40 Score=287.14 Aligned_cols=117 Identities=51% Similarity=0.746 Sum_probs=109.7
Q ss_pred HHhhccccceeeeeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeecC
Q psy10618 192 LLAQGAACNVLYLVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGL 271 (339)
Q Consensus 192 ll~~gaaCnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~l 271 (339)
||+|||||||+||||+|||+|+|++||+|||.+++..+++|.+|+||||||.||||||||+||+|||||||+++|+||++
T Consensus 1 ll~qgaa~nv~yLgS~evesltg~~av~kAv~~~l~~~~~~~~t~vh~kVS~qGItLtDn~rk~ffrrhypl~~Vs~ca~ 80 (138)
T cd01213 1 LLAQGAACNVLYLGSVDTESLTGNEAIKKAIAQCSGQAPDPQATEVHFKVSSQGITLTDNTRKKFFRRHYKVDSVIFCAI 80 (138)
T ss_pred CcccccccceeeeeeEeeccccCcHHHHHHHHHHHhcCCCCCceEEEEEEEcCCeeeeccccceeehhhCCcCeEEEEee
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCccccCCccccccccccchhHHHHhcCCCChhhhhccee
Q psy10618 272 DPEDSRCLTRPWCISKSHCSCDKNFKSCLKSTKSAAADVMGEF 314 (339)
Q Consensus 272 DP~dRrW~~~~~~~~~s~C~cd~~F~~CLk~~~~~~sn~vG~~ 314 (339)
||++|+|.+.+-+ .-.+.|+|++|.++.+.+|+|+.|
T Consensus 81 dp~n~~~~~~~~~------~~kriFgFVar~~~~~~~~~ChvF 117 (138)
T cd01213 81 DPEERMWENEGAI------AKARIFAFVARIPHSSTDNACHVF 117 (138)
T ss_pred CCccccccccccc------cccEEEEEEEecCCCCCCeeEEEe
Confidence 9999999986432 246899999999888888999876
No 3
>PF05826 Phospholip_A2_2: Phospholipase A2; InterPro: IPR001211 Phospholipase A2 (3.1.1.4 from EC) (PLA2) is a small lipolytic enzyme that releases fatty acids from the second carbon group of glycerol. It is involved in a number of physiologically important cellular processes, such as the liberation of arachidonic acid from membrane phospholipids []. It plays a pivotal role in the biosynthesis of prostaglandin and other mediators of inflammation. PLA2 has four to seven disulphide bonds and binds a calcium ion that is essential for activity. Within the active enzyme, the alpha amino group is involved in a conserved hydrogen-bonding network linking the N-terminal region to the active site. The side chains of two conserved residues, His and Asp, participate in the catalytic network. Many PLA2's are widely distributed in snakes, lizards, bees and mammals. In mammals there are at least four forms: pancreatic, membrane-associated as well as two less well characterised forms. The venom of most snakes contains multiple forms of PLA2. Some of them are presynaptic neurotoxins which inhibit neuromuscular transmission by blocking acetylcholine release from the nerve termini. Some of the proteins in this family are allergens. Allergies are hypersensitivity reactions of the immune system to specific substances called allergens (such as pollen, stings, drugs, or food) that, in most people, result in no symptoms. A nomenclature system has been established for antigens (allergens) that cause IgE-mediated atopic allergies in humans [WHO/IUIS Allergen Nomenclature Subcommittee King T.P., Hoffmann D., Loewenstein H., Marsh D.G., Platts-Mills T.A.E., Thomas W. Bull. World Health Organ. 72:797-806(1994)]. This nomenclature system is defined by a designation that is composed of the first three letters of the genus; a space; the first letter of the species name; a space and an arabic number. In the event that two species names have identical designations, they are discriminated from one another by adding one or more letters (as necessary) to each species designation. The allergens in this family include allergens with the following designations: Api m 1.; GO: 0004623 phospholipase A2 activity, 0005509 calcium ion binding, 0016042 lipid catabolic process; PDB: 1POC_A.
Probab=100.00 E-value=1e-35 Score=245.27 Aligned_cols=54 Identities=50% Similarity=1.043 Sum_probs=40.0
Q ss_pred ccCCccccCCCCCCCCccCCCCccccchhhccccCCccccccCcccccccCCCC
Q psy10618 64 IIPGTKWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIRAHTNRYNITNDSM 117 (339)
Q Consensus 64 i~PGTkWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~~~~~kygLtN~sg 117 (339)
|+|||||||+||+|.+|+|||.+.+||+|||+||+||++|+++++||||+|...
T Consensus 1 i~pGT~WCG~gn~a~~~~dlG~~~~tD~CCR~HD~C~~~I~~~~~k~gl~N~~~ 54 (99)
T PF05826_consen 1 IYPGTKWCGPGNIAKNYSDLGEFKETDRCCREHDHCPDKIPPGETKYGLHNPRP 54 (99)
T ss_dssp B-TT-SSSBSS---SSTT---SSHHHHHHHHHHHT-SSEE-TT-EETTEE--SS
T ss_pred CCCCCcccCCCCCccCcccccccHHHHHHHHhhccCCCccCCCccccccccCCc
Confidence 799999999999999999999999999999999999999999999999999876
No 4
>cd04704 PLA2_bee_venom_like PLA2_bee_venom_like: A sub-family of Phospholipase A2, similar to bee venom PLA2. PLA2 is a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers. Bee venom PLA2 has fewer conserved disulfide bridges than most canonical PLA2s.
Probab=100.00 E-value=3.5e-34 Score=235.73 Aligned_cols=50 Identities=54% Similarity=1.090 Sum_probs=48.0
Q ss_pred cccCCccccCCCCCCCCccCCCCccccchhhccccCCccccccCcccccc
Q psy10618 63 GIIPGTKWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIRAHTNRYNI 112 (339)
Q Consensus 63 ~i~PGTkWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~~~~~kygL 112 (339)
+|+|||||||+||+|.+|+|||.+.+||+|||+||+||++|.++++|||+
T Consensus 1 ~~~pGTkWCG~Gn~a~~~~dlG~~~~tD~CCr~HD~C~~~i~~~~~kyg~ 50 (97)
T cd04704 1 FIVPGTKWCGPGNIATNYSDLGAFRETDKCCREHDHCPDIISAGEYKYGL 50 (97)
T ss_pred CccCCCeecCCCCCCCCcccccCccccchHHHccccCcCcccccccccCc
Confidence 48999999999999999999999999999999999999999999988877
No 5
>PF08416 PTB: Phosphotyrosine-binding domain; InterPro: IPR013625 The phosphotyrosine-binding domain (PTB, also phosphotyrosine-interaction or PI domain) of tensin tends to be found at the C terminus of a protein. Tensin is a multi-domain protein that binds to actin filaments and functions as a focal-adhesion molecule (focal adhesions are regions of plasma membrane through which cells attach to the extracellular matrix). Human tensin has actin-binding sites, an SH2 (IPR000980 from INTERPRO) domain and a region similar to the tumour suppressor PTEN []. The PTB domain interacts with the cytoplasmic tails of beta integrin by binding to an NPXY motif []. ; GO: 0005515 protein binding; PDB: 3HQC_A 2DKQ_A 2LOZ_A 2CY5_A 2CY4_A 2GJY_A 1WVH_A.
Probab=99.92 E-value=5.8e-26 Score=194.97 Aligned_cols=98 Identities=42% Similarity=0.631 Sum_probs=89.6
Q ss_pred ccceeeeeeeccCCccchHHHHHHHHh--hhCCCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCC
Q psy10618 198 ACNVLYLVSVDTESLTGPQAVTRAINS--LFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPED 275 (339)
Q Consensus 198 aCnvlyL~sv~~esltG~~Av~kAv~~--~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~d 275 (339)
||||.||+++++|+++|++||++|+.. .|+.++.+.++.|||||++|||||||++||.|| ||||+++|+||++||++
T Consensus 1 ~~~V~hL~T~~~e~~~g~~~v~d~i~~l~~l~~~~~~w~q~~~lkV~~~~v~L~D~~~k~~l-e~yPl~~I~~c~~~~~~ 79 (131)
T PF08416_consen 1 AYNVEHLATFDVESLTGPQAVEDAIRRLKLLEAKGRIWPQEMHLKVSDQGVTLTDIETKEFL-EHYPLSSIQFCGADPDS 79 (131)
T ss_dssp EEEEEEEEEEEECTTSCCCHHHHHHHHHHHHHCSS-SS-EEEEEEEETTEEEEEESSTSSEC-EEEECCCEEEEEEETTT
T ss_pred CcEEEEEEEEEcCCCcchhhHHHHHHHHHhhccCCCcccEEEEEEEeCCeEEEEECcccchh-hhCCHhHeeeccccCCC
Confidence 699999999999999999999998864 578899999999999999999999999999999 99999999999999999
Q ss_pred CccccCCccccccccccchhHHHHhcCCCChhhhh
Q psy10618 276 SRCLTRPWCISKSHCSCDKNFKSCLKSTKSAAADV 310 (339)
Q Consensus 276 RrW~~~~~~~~~s~C~cd~~F~~CLk~~~~~~sn~ 310 (339)
|+|.+ +|++++|+.+....|+
T Consensus 80 ~~~~~--------------il~fV~r~~~~~~~~~ 100 (131)
T PF08416_consen 80 RRYNS--------------ILGFVVRKPGSSKPNV 100 (131)
T ss_dssp TEECB--------------EEEEEEEETTCCCEEE
T ss_pred Cccce--------------EEEEEEecCCCCCCcE
Confidence 99986 8999999888776665
No 6
>cd01212 JIP JNK-interacting protein (JIP) Phosphotyrosine-binding (PTB) domain. JNK-interacting protein (JIP) Phosphotyrosine-binding (PTB) domain. JIP is a mitogen-activated protein kinase scaffold protein. JIP consists of a C-terminal SH3 domain, followed by a PTB domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=99.44 E-value=1.7e-13 Score=120.64 Aligned_cols=111 Identities=23% Similarity=0.476 Sum_probs=87.0
Q ss_pred cceeeeeeeccCCccchHHHHHHHHhhhC----CCCCCCceEEEEEEecceeeeecccccccccc-----ccCCCceeee
Q psy10618 199 CNVLYLVSVDTESLTGPQAVTRAINSLFG----TKPLPHAAVVHFKVSSQGITLTDNKRQLFFRR-----HYPVASISYC 269 (339)
Q Consensus 199 CnvlyL~sv~~esltG~~Av~kAv~~~l~----~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRR-----HYp~n~v~fC 269 (339)
..|-|||||+|+.+.|.+.+..|+.+++. .+..++++.|+++||.+||+|+|.++|.++++ +||+.+|+||
T Consensus 5 f~vkyLGsveV~~~kG~~v~~~A~rki~~~~k~~~~~~~~~~v~L~VS~~Girl~D~~t~~~~~~~~~~~f~~l~nISFC 84 (148)
T cd01212 5 FLLGYLGSVEVLAHKGNGVLCQAMRKIVGEYKNSEESPTPQTCILEISDRGLRMVDRSGPNKDKKPCIDFFYSLKNISFC 84 (148)
T ss_pred EEeEecceEEecCCCCcHHHHHHHHHHHHHHHhhccCCCCcEEEEEEecCcEEEEecCCCcccccchhhccccccceEEE
Confidence 56889999999999999888888887764 34456789999999999999999999987764 5889999999
Q ss_pred cCCCCCCccccCCccccccc----cccchhHHHHhcCCCChhhhhcceee
Q psy10618 270 GLDPEDSRCLTRPWCISKSH----CSCDKNFKSCLKSTKSAAADVMGEFY 315 (339)
Q Consensus 270 ~lDP~dRrW~~~~~~~~~s~----C~cd~~F~~CLk~~~~~~sn~vG~~Y 315 (339)
+.||+|.||-- ++ ++.. =.|. .|- .++....++..||..|
T Consensus 85 a~d~~~~r~F~--FI-ak~~~~~~~~CH-VF~--s~~~~~~I~~aIG~AF 128 (148)
T cd01212 85 GFHPRDHRYFG--FI-TKHPLLQRFACH-VFK--SSESTRPVAEAVGRAF 128 (148)
T ss_pred EEcCCCCcEEE--EE-eccCCCCceEEE-EEE--eCCcchHHHHHHHHHH
Confidence 99999999853 21 2211 1344 553 3666777888888764
No 7
>cd04705 PLA2_group_III_like PLA2_group_III_like: A sub-family of Phospholipase A2, similar to human group III PLA2. PLA2 is a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers.
Probab=99.24 E-value=1.8e-12 Score=107.95 Aligned_cols=55 Identities=25% Similarity=0.393 Sum_probs=47.3
Q ss_pred cCCCCccccchhhccccCCccccccCcccccccCCCCcchhhhhhhhccccCCCCceeccCCCC
Q psy10618 81 FDLGSEIKLDKCCRTHDLCPSKIRAHTNRYNITNDSMYTNNELVRHFLIEPTPRGVRLKGCSNE 144 (339)
Q Consensus 81 ~dLG~~~~tD~CCR~HD~C~~~I~~~~~kygLtN~sgyT~~~lvrHfLIe~~~~gv~lkGc~~E 144 (339)
++||.+.++|+|||+||+||.+|.++++||||+|.+.++.+ |+- .+-+++.|...
T Consensus 26 ~~lG~~~~~DrCCR~HD~Cp~~I~~~~~k~gl~N~~~~tis----HCd-----CD~rf~~CL~~ 80 (100)
T cd04705 26 LSEGEFKEPDRCCWKHKQCPGHIIPPFSSDGHHNFHLHSVS----HCD-----CDSRLKDCLRL 80 (100)
T ss_pred cccccccchhhhhhhhhcCccccCCcccccceecCCCcccc----ccc-----HHHHHHHHHHH
Confidence 79999999999999999999999999999999999999875 663 34466666543
No 8
>cd00934 PTB Phosphotyrosine-binding (PTB) domain. Phosphotyrosine-binding (PTB) domain; PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. The PTB domain of SHC binds to a NPXpY sequence. More recent studies have found that some types of PTB domains such as the neuronal protein X11 and in the cell-fate determinant protein Numb can bind to peptides which are not tyrosine phosphorylated; whereas, other PTB domains can bind motifs lacking tyrosine residues altogether.
Probab=99.18 E-value=5.7e-11 Score=96.79 Aligned_cols=80 Identities=36% Similarity=0.526 Sum_probs=71.5
Q ss_pred cccceeeeeeeccCCccchHHHHHHHHhhhCCCC--CCCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCC
Q psy10618 197 AACNVLYLVSVDTESLTGPQAVTRAINSLFGTKP--LPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPE 274 (339)
Q Consensus 197 aaCnvlyL~sv~~esltG~~Av~kAv~~~l~~~~--~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~ 274 (339)
..++|.|||++++...+|.+.++.|+..+.+... .+.++.|+++||.+||+|.|.+.+....+| |+..|+||+.||+
T Consensus 2 ~~f~v~ylG~~~v~~~~g~~~~~~ai~~l~~~~~~~~~~~~~v~l~vs~~gv~l~d~~~~~~l~~~-~l~~Is~~~~~~~ 80 (123)
T cd00934 2 ISFNVKYLGSVEVPEPRGSQVVRDAIRKLKAASKQGGEKGQKVILSVSSDGVKLIDPKTKEVLASH-PIRRISFCAADPD 80 (123)
T ss_pred cEEEEEEEEEEEecCCCCchHHHHHHHHHHHhhhhcccCCCEEEEEEEcCcEEEEeCCCCcEEEee-ccceEEEEECCCC
Confidence 4578999999999999999999999999997664 467889999999999999999998887776 9999999999997
Q ss_pred CCc
Q psy10618 275 DSR 277 (339)
Q Consensus 275 dRr 277 (339)
+.+
T Consensus 81 ~~~ 83 (123)
T cd00934 81 DLR 83 (123)
T ss_pred CCc
Confidence 443
No 9
>smart00462 PTB Phosphotyrosine-binding domain, phosphotyrosine-interaction (PI) domain. PTB/PI domain structure similar to those of pleckstrin homology (PH) and IRS-1-like PTB domains.
Probab=99.12 E-value=1.5e-10 Score=96.24 Aligned_cols=82 Identities=29% Similarity=0.457 Sum_probs=71.8
Q ss_pred hccccceeeeeeeccCCccchHHHHHHHHhhhC--CCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeecCC
Q psy10618 195 QGAACNVLYLVSVDTESLTGPQAVTRAINSLFG--TKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLD 272 (339)
Q Consensus 195 ~gaaCnvlyL~sv~~esltG~~Av~kAv~~~l~--~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lD 272 (339)
.|..++|.|||++++....|.+.++.||..++. ....+.+..|++.||.+||.|+|.+.+- ....||+..|+||+.|
T Consensus 2 ~~~~f~v~YLGs~~v~~~~g~~~~~~ai~~l~~~~~~~~~~~~~v~l~vs~~gv~v~~~~~~~-~l~~~~l~~Isf~~~~ 80 (134)
T smart00462 2 SGVSFRVKYLGSVEVPEARGLQVVQEAIRKLRAAQGSEKKEPQKVILSISSRGVKLIDEDTKA-VLHEHPLRRISFCAVG 80 (134)
T ss_pred CceEEEEEEEEEEEecCCCCcHHHHHHHHHHHHhhhhccCCCCEEEEEEECCcEEEEECCCCe-EEEEccccceEEEecC
Confidence 356789999999999999999999999999997 3445678899999999999999999884 3346999999999999
Q ss_pred CCCCc
Q psy10618 273 PEDSR 277 (339)
Q Consensus 273 P~dRr 277 (339)
|.+.+
T Consensus 81 ~~~~~ 85 (134)
T smart00462 81 PDDLD 85 (134)
T ss_pred CCCCc
Confidence 98664
No 10
>cd01267 CED6_AIDA1b Phosphotyrosine-binding (PTB) domain, phosphotyrosine-interaction (PI) domain. Phosphotyrosine-binding (PTB) domain, phosphotyrosine-interaction (PI) domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=99.12 E-value=1.5e-10 Score=98.64 Aligned_cols=79 Identities=27% Similarity=0.404 Sum_probs=68.4
Q ss_pred cceeeeeeeccCCccchHHHHHHHHhhhCCCCC-----CCceEEEEEEecceeeeeccccccccccccCCCceeeecCCC
Q psy10618 199 CNVLYLVSVDTESLTGPQAVTRAINSLFGTKPL-----PHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDP 273 (339)
Q Consensus 199 CnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~-----p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP 273 (339)
.++-|||+++++...|.+++++|+..+.++... ..++.|++.||.+||+|+|...|... .+||+..|+||+.||
T Consensus 4 f~vkyLGs~~V~~~~g~~~~~~Ai~~l~~~~~~~~~~~~k~~~V~L~IS~~gi~i~d~~t~~~l-~~~~i~~ISfc~~d~ 82 (132)
T cd01267 4 YRAKFLGSLEIGKLKGTEVAREAIRKLKFSRILKTAEWEKIPKVELDISIKGVKIIDPKTKTVL-HGHPLYNISCCAQDK 82 (132)
T ss_pred EEEEEEEEEEecCCCChHHHHHHHHHHHhhhhcchhccCCCCeEEEEEEcCcEEEEeCCCCcEE-EEcccceEEEEecCC
Confidence 467899999999999999999999999765432 24577999999999999999988775 677999999999999
Q ss_pred CCCcc
Q psy10618 274 EDSRC 278 (339)
Q Consensus 274 ~dRrW 278 (339)
+|.+.
T Consensus 83 ~~~~~ 87 (132)
T cd01267 83 EDLRF 87 (132)
T ss_pred CCCeE
Confidence 98764
No 11
>cd00618 PLA2_like PLA2_like: Phospholipase A2, a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids (PC or phosphatidylethanolamine), usually in a metal-dependent reaction, to generate lysophospholipid (LysoPL) and a free fatty acid (FA). The resulting products are either dietary or used in synthetic pathways for leukotrienes and prostaglandins. Often, arachidonic acid is released as a free fatty acid and acts as second messenger in signaling networks. Secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis (LysoPL and FA) cannot form bilayers leading to a change in membrane conformation and ultimately
Probab=98.87 E-value=9.2e-10 Score=86.51 Aligned_cols=46 Identities=28% Similarity=0.447 Sum_probs=42.1
Q ss_pred cCCccccCCCCCCCCccCCCCccccchhhccccCCccccccCcccccc
Q psy10618 65 IPGTKWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIRAHTNRYNI 112 (339)
Q Consensus 65 ~PGTkWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~~~~~kygL 112 (339)
.|+++|||.|+.+.+|.+.+ -++|+|||.||+|++.|...+.+++.
T Consensus 1 ~~ygc~CG~g~~~~~~g~p~--D~~D~CC~~HD~Cy~~~~~~~~~~~~ 46 (83)
T cd00618 1 LPYGCYCGPGGSACPSGQPV--DETDRCCRKHDCCYDQISDGGCCDGC 46 (83)
T ss_pred CCcCcccCCCCcCCCCCCCC--CcchhhhhhCccHhhhhhccCCCCCc
Confidence 47899999999999998888 69999999999999999999998884
No 12
>cd01273 CED-6 CED-6 Phosphotyrosine-binding (PTB) domain. CED-6 Phosphotyrosine-binding (PTB) domain. CED6 is an adaptor protein involved in the engulfment of apoptotic cells. It has a C-terminal PTB domain, which can bind to NPXY motifs. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=98.68 E-value=6.5e-08 Score=84.11 Aligned_cols=88 Identities=22% Similarity=0.381 Sum_probs=71.5
Q ss_pred HHHhhccccceeeeeeeccCCccchHHHHHHHHhhhCC------C--CCCCceEEEEEEecceeeeeccccccccccccC
Q psy10618 191 LLLAQGAACNVLYLVSVDTESLTGPQAVTRAINSLFGT------K--PLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYP 262 (339)
Q Consensus 191 ~ll~~gaaCnvlyL~sv~~esltG~~Av~kAv~~~l~~------~--~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp 262 (339)
.|+..+....+-|||++++....|.+.++.||+.+... . ....++.|++.||.+||.++|...|-- --++|
T Consensus 3 ~l~~g~v~f~vkyLG~~eV~~~~g~~v~~eAi~ki~~a~~~k~~~~~~~~k~~~V~L~IS~~GI~v~d~~t~~~-~~~~~ 81 (142)
T cd01273 3 YLINGHVEYVAKFLGCVEVDQPKGSEVVREAIRKLRFARDLKKSEQTRTAKLQKVEIRISIDGVIIAEPKTKAP-MHTFP 81 (142)
T ss_pred hHccCceEEEEEEeeeEEecCCCCchHHHHHHHHHHHHHhhhhccccccccCcEEEEEEECCeEEEEEcCCCcE-EEEcC
Confidence 35555578899999999999999999999999987521 1 112357899999999999999976653 36899
Q ss_pred CCceeeecCCCCCCccc
Q psy10618 263 VASISYCGLDPEDSRCL 279 (339)
Q Consensus 263 ~n~v~fC~lDP~dRrW~ 279 (339)
+..||||+-||++.|+-
T Consensus 82 i~~ISfca~d~~~~r~F 98 (142)
T cd01273 82 LGRISFCADDKDDKRMF 98 (142)
T ss_pred cceEEEEecCCCCCeEE
Confidence 99999999999988754
No 13
>cd01268 Numb Numb Phosphotyrosine-binding (PTB) domain. Numb Phosphotyrosine-binding (PTB) domain. Numb is a membrane associated adaptor protein, which is a determinant of asymmetric cell division. Numb has an N-terminal PTB domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=98.47 E-value=3.8e-07 Score=80.06 Aligned_cols=116 Identities=20% Similarity=0.347 Sum_probs=83.7
Q ss_pred HHhhcc-ccceeeeeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeec
Q psy10618 192 LLAQGA-ACNVLYLVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCG 270 (339)
Q Consensus 192 ll~~ga-aCnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~ 270 (339)
.|..|- ..++=|||+++++...|.+.++.|+..+..+.. .+.-|.+.||.+||.|.|..=|-- --++|+..|+||+
T Consensus 8 ~~~~g~~~f~vKyLG~veV~~~rG~~v~~~A~~klk~~~~--k~~kv~L~VS~~Gi~vvd~~Tk~~-i~~~~i~~ISfca 84 (138)
T cd01268 8 AVRTGTCSFPVKYLGHVEVDESRGMQVCEDALKRLKASRR--KPVKAVLWVSGDGLRVVDEKTKGL-IVDQTIEKVSFCA 84 (138)
T ss_pred HHhcCceeEEeEecceEEccCcCCChHHHHHHHHHHhhcc--CCCEEEEEEecCcEEEEecCCCcE-EEEEeEEEEEEEe
Confidence 444554 778899999999999999999999998876543 466799999999999999865432 2347999999999
Q ss_pred CCCCCCccccCCcccccccc----ccchhHHHHhcCCCChhhhhcceee
Q psy10618 271 LDPEDSRCLTRPWCISKSHC----SCDKNFKSCLKSTKSAAADVMGEFY 315 (339)
Q Consensus 271 lDP~dRrW~~~~~~~~~s~C----~cd~~F~~CLk~~~~~~sn~vG~~Y 315 (339)
-||.|.|--- ++. +..= .|+ .| .|.|.....++..||..|
T Consensus 85 ~D~~d~r~Fa--yIa-kd~~~~r~~CH-vF-~~~k~sa~~i~~avG~AF 128 (138)
T cd01268 85 PDRNFDRGFS--YIC-RDGTTRRWMCH-GF-LAVKDTGERLSHAVGCAF 128 (138)
T ss_pred cCCCCCcEEE--EEe-cCCCcccEEEE-EE-EeeccchhHHHHHHHHHH
Confidence 9999887432 221 1110 233 22 233555666778888775
No 14
>PF00640 PID: Phosphotyrosine interaction domain (PTB/PID) A page on PI domains.; InterPro: IPR006020 The PI domain has a similar structure to the insulin receptor substrate-1 PTB domain, a 7-stranded beta-sandwich, capped by a C-terminal helix. However, the PI domain contains an additional short N-terminal helix and a large insertion between strands 1 and 2, which forms a helix and 2 long connecting loops. The substrate peptide fits into a surface cleft formed from the C-terminal helix and strand 5 [].; GO: 0005515 protein binding; PDB: 1WGU_A 2YT0_A 2YT1_A 2YSZ_A 2ROZ_B 3SO6_A 2DYQ_A 1AQC_A 1X11_B 1WJ1_A ....
Probab=98.45 E-value=3.1e-07 Score=76.60 Aligned_cols=77 Identities=34% Similarity=0.496 Sum_probs=63.7
Q ss_pred ceeeeeeeccCCc------cchHHHHHHHHhhhCC---------CCCCCceEEEEEEecceeeeeccccccccccccCCC
Q psy10618 200 NVLYLVSVDTESL------TGPQAVTRAINSLFGT---------KPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVA 264 (339)
Q Consensus 200 nvlyL~sv~~esl------tG~~Av~kAv~~~l~~---------~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n 264 (339)
.|-||||+++... .|.+.++.||..++.. .....++.|.+.||.+||+|.|...+-- --++|+.
T Consensus 2 ~vkYLGs~~V~~~~~~~~~~g~~~v~~ai~~~~~~~~~~~~~~~~~~~~~~~V~l~vs~~gI~v~~~~t~~~-l~~~~i~ 80 (140)
T PF00640_consen 2 EVKYLGSVEVSSSRRGDKSRGSDVVREAIQRLKAEKIAKSKKSKSNKKKPQKVTLNVSSDGIKVIDPDTGEV-LMSHPIR 80 (140)
T ss_dssp EEEEEEEEEESSSSSTCHHHHHHHHHHHHHHHHHHCCCSHHHHHTTTSTSEEEEEEEETTEEEEEETTTTCE-EEEEEGG
T ss_pred EEEEEEEEEECCccCCCcchhHHHHHHHHHHHHhhhhhhhhccccccccCeEEEEEEcCCeEEEecCccccc-cccCCcc
Confidence 3679999999999 7899999999998865 3444678999999999999999765332 2368999
Q ss_pred ceeeecC-CCCCCc
Q psy10618 265 SISYCGL-DPEDSR 277 (339)
Q Consensus 265 ~v~fC~l-DP~dRr 277 (339)
.|+||+. ||++.+
T Consensus 81 ~Is~~~~~d~~~~~ 94 (140)
T PF00640_consen 81 RISFCAVGDPDDKR 94 (140)
T ss_dssp GEEEEEESSTTETT
T ss_pred ceEEEEecCCCcce
Confidence 9999999 998655
No 15
>cd01216 Fe65 Fe65 Phosphotyrosine-binding (PTB) domain, phosphotyrosine-interaction (PI) domain. Fe65 Phosphotyrosine-binding (PTB) domain, phosphotyrosine-interaction (PI) domain. Fe65 is an amyloid beta A4 precursor (APP) protein-binding. It contains an N-terminal WW domain followed by two PTB domains. The C-terminal PTB domain is responsible for APP binding. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=98.40 E-value=8.1e-07 Score=76.13 Aligned_cols=76 Identities=17% Similarity=0.215 Sum_probs=66.6
Q ss_pred cceeeeeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCC
Q psy10618 199 CNVLYLVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPED 275 (339)
Q Consensus 199 CnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~d 275 (339)
..|-|||+++++...|.+++.+||..++........+.|++.||..||+|.|.+-+- -.--+|+..|+|||.|.++
T Consensus 4 F~VkyLG~~eV~~~~g~~vv~~ai~~L~~~~~~~~~~~v~l~Vs~~~l~l~d~~t~~-~l~~~~i~~Isf~~~gk~~ 79 (123)
T cd01216 4 FAVRSLGWVEVAEEDGSEALNKAIDDLSSCSNWEDWKDLNMDLAPSTLSLIDPDNLT-VLHECRVRYLSFWGVGRDV 79 (123)
T ss_pred EEEEeeeeEEECCCCCHHHHHHHHHHHHhccccccCeEEEEEEecCcEEEEcCCCCe-EEEEEEeeEEEEEEcCCCC
Confidence 468999999999999999999999999976666677889999999999999988643 3446899999999999777
No 16
>cd04705 PLA2_group_III_like PLA2_group_III_like: A sub-family of Phospholipase A2, similar to human group III PLA2. PLA2 is a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers.
Probab=98.32 E-value=1.8e-07 Score=78.28 Aligned_cols=35 Identities=37% Similarity=0.768 Sum_probs=28.8
Q ss_pred ccccccccccchhHHHHhcCCCCh-----hhhhcceeeee
Q psy10618 283 WCISKSHCSCDKNFKSCLKSTKSA-----AADVMGEFYFN 317 (339)
Q Consensus 283 ~~~~~s~C~cd~~F~~CLk~~~~~-----~sn~vG~~YFn 317 (339)
..+|+|||+||++|+.||++++++ .++++|.+|||
T Consensus 61 ~~~tisHCdCD~rf~~CL~~~n~~~~~~~~s~~lG~~~Fn 100 (100)
T cd04705 61 HLHSVSHCDCDSRLKDCLRLSSSSRVGPTCSHLLGTTCFN 100 (100)
T ss_pred CCcccccccHHHHHHHHHHHcCCccccccHHHHhcccccC
Confidence 467999999999999999999884 46666666665
No 17
>cd01274 AIDA-1b AIDA-1b Phosphotyrosine-binding (PTB) domain. AIDA-1b Phosphotyrosine-binding (PTB) domain. AIDA-1b is an amyloid-beta precursor protein interacting protein. It consists of ankyrin repeats, a SAM domain and a C-terminal PTB domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=98.29 E-value=1.5e-06 Score=74.89 Aligned_cols=80 Identities=16% Similarity=0.230 Sum_probs=66.1
Q ss_pred cceeeeeeeccCCccchHHHHHHHHhhhCCCC-CCCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCCCc
Q psy10618 199 CNVLYLVSVDTESLTGPQAVTRAINSLFGTKP-LPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPEDSR 277 (339)
Q Consensus 199 CnvlyL~sv~~esltG~~Av~kAv~~~l~~~~-~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~dRr 277 (339)
.++-||||++++...|...+++||..+..... ...++.|.+.||.+||.+.|..-|--.- ++|+..|+||+-||.|.+
T Consensus 4 f~akyLGs~eV~~~~G~~~~~~Am~kik~~~~~~~k~~~V~L~IS~~Gv~v~d~~tk~~i~-~~~i~~ISf~~~D~~d~~ 82 (127)
T cd01274 4 YRAHYLGSLEIGELEGTDSTHAAMTKIKESIIDWETIPRVTLDLTCNGVKFIDETFKTLID-GHGIYNIRCVCQDREDLN 82 (127)
T ss_pred EEEEccceEEccCCCCcHHHHHHHHHHHHhhhccCCCCEEEEEEeCCeEEEEECCCCeEEE-EeeeeEEEEEecCCCCce
Confidence 35679999999999999999999999865431 1345789999999999999987665443 469999999999999877
Q ss_pred cc
Q psy10618 278 CL 279 (339)
Q Consensus 278 W~ 279 (339)
+-
T Consensus 83 ~F 84 (127)
T cd01274 83 FF 84 (127)
T ss_pred EE
Confidence 65
No 18
>cd01214 CG8312 CG8312 Phosphotyrosine-binding (PTB) domain. CG8312 Phosphotyrosine-binding (PTB) domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=98.28 E-value=7.7e-07 Score=77.89 Aligned_cols=83 Identities=22% Similarity=0.321 Sum_probs=67.5
Q ss_pred ccceeeeeeeccCCccchHHHHHHHHhhhCCCCCC--CceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCC
Q psy10618 198 ACNVLYLVSVDTESLTGPQAVTRAINSLFGTKPLP--HAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPED 275 (339)
Q Consensus 198 aCnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~p--~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~d 275 (339)
.++|.|||.+-|+.-.|..++.+||..+......- ...-|.+.||.+||.++|.++.+ ..||+..|+||..|+.-
T Consensus 3 ty~VkYLG~~~t~~~~Geg~t~~av~~I~~~~~~~~k~~~km~L~Vsp~GI~~~~~~~~~---~~~~i~RIsYCsad~~~ 79 (133)
T cd01214 3 TYTVLYLGNVLTIQARGEGCTEKALGKIWSKYEAGARQDTKMKLTVSASGLKAVTAQRGL---TEYWAHRITYCVAPARY 79 (133)
T ss_pred cEEEEEcccccccccCCCccHHHHHHHHHHHHhhcccccceEEEEEcCCceEEEeccccc---eEEEEeeeeeecCCcCC
Confidence 47899999999999999999999999887642211 24569999999999999999765 58999999999999883
Q ss_pred CccccCCccc
Q psy10618 276 SRCLTRPWCI 285 (339)
Q Consensus 276 RrW~~~~~~~ 285 (339)
=..+.|++
T Consensus 80 --p~VFa~I~ 87 (133)
T cd01214 80 --PKVFCWIY 87 (133)
T ss_pred --CcEEEEEE
Confidence 24445555
No 19
>PF14719 PID_2: Phosphotyrosine interaction domain (PTB/PID)
Probab=98.28 E-value=1e-06 Score=80.62 Aligned_cols=82 Identities=23% Similarity=0.383 Sum_probs=69.0
Q ss_pred cceeeeeeeccCCccchHHHHHHHHhhhCCCCC-CCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCCCc
Q psy10618 199 CNVLYLVSVDTESLTGPQAVTRAINSLFGTKPL-PHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPEDSR 277 (339)
Q Consensus 199 CnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~-p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~dRr 277 (339)
.+|.|||++.+...-|+..+++||..+...... .....+.+.|+.+||.+++.++++-+ |+++.|+||..|++-
T Consensus 2 y~V~YLG~~~t~~~~Gegct~kpV~~lw~~~~~~k~~~~m~L~V~~~Gik~~~~~~~~~~---y~i~RItYC~ad~~~-- 76 (182)
T PF14719_consen 2 YKVRYLGNVLTRGAKGEGCTEKPVSKLWRRYKQGKPDKKMKLTVSPSGIKMETKDKGLTE---YWIHRITYCTADPQH-- 76 (182)
T ss_pred eEEEEecceecccccccchHHHHHHHHHHHhccCCCCceeEEEEcCCceEEEECCCCceE---EEeeeEEEecCCCCC--
Confidence 579999999999999999999999999875333 24678899999999999999977744 999999999999874
Q ss_pred cccCCccc
Q psy10618 278 CLTRPWCI 285 (339)
Q Consensus 278 W~~~~~~~ 285 (339)
=..+.|+|
T Consensus 77 PrVFawIy 84 (182)
T PF14719_consen 77 PRVFAWIY 84 (182)
T ss_pred CceEEEEE
Confidence 34456666
No 20
>smart00085 PA2c Phospholipase A2.
Probab=98.15 E-value=9.5e-07 Score=75.20 Aligned_cols=45 Identities=22% Similarity=0.211 Sum_probs=37.0
Q ss_pred ccccCCccccCCCCCCCCccCCCCccccchhhccccCCccccccCccccc
Q psy10618 62 NGIIPGTKWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIRAHTNRYN 111 (339)
Q Consensus 62 ~~i~PGTkWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~~~~~kyg 111 (339)
+++.++|.||+-|+.+.... .-.+|+|||+||+|.+.|+. +..+.
T Consensus 17 ~~~~y~~YGCyCG~gg~G~p----vD~~D~CC~~HD~Cy~~~~~-~~C~~ 61 (117)
T smart00085 17 AWLSYGDYGCYCGWGGSGTP----VDATDRCCFVHDCCYGKAEK-EGCNP 61 (117)
T ss_pred cccchhccCcccCCCCCCCc----cccccchhhhcCchhhhccc-CCCcc
Confidence 46889999999999876553 56899999999999999987 55444
No 21
>cd01215 Dab Disabled (Dab) Phosphotyrosine-binding domain. Disabled (Dab) Phosphotyrosine-binding domain. Dab is a cystosolic adaptor protein, which binds to the cytoplasmic tails of lipoprotein receptors, such as ApoER2 and VLDLR, via its PTB domain. The dab PTB domain has a preference for unphosphorylated tyrosine within an NPxY motif. Additionally, the Dab PTB domain, which is structurally similar to PH domains, binds to phosphatidlyinositol phosphate 4,5 bisphosphate in a manner characteristic of phosphoinositide binding PH domains.
Probab=97.61 E-value=0.00015 Score=64.13 Aligned_cols=85 Identities=19% Similarity=0.294 Sum_probs=66.8
Q ss_pred HhhccccceeeeeeeccCCccchHHHHHHHHhhhCC--CCCCCceEEEEEEecceeeeeccccccccccccCCCceeeec
Q psy10618 193 LAQGAACNVLYLVSVDTESLTGPQAVTRAINSLFGT--KPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCG 270 (339)
Q Consensus 193 l~~gaaCnvlyL~sv~~esltG~~Av~kAv~~~l~~--~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~ 270 (339)
-..|-..++=|||+++++..-|....+.|+..+-.. ...-...-|.+.||..||.++|..-+ -.-=|+|++.|+||+
T Consensus 9 ~g~gv~f~aKylG~~eV~e~RG~~v~~~Ai~klk~~~k~~~~kk~kV~L~IS~dGi~v~D~~T~-~ll~~~~i~rISfca 87 (139)
T cd01215 9 QGNGVSYKAKLIGIQEVDKARGDAMCAEAMRKAKSIIKGAGAHKTRITLQINIDGIKVLDEKTG-AVLHHHPVHRISFIA 87 (139)
T ss_pred eCCcEEEEEEecccEecccCCchHHHHHHHHHHHHHhhhhccccceEEEEEccCCEEEEcCCCC-cEEEeeceeeEEEEe
Confidence 345667888899999999999999888888876431 11224567999999999999998433 334588999999999
Q ss_pred CCCCCCcc
Q psy10618 271 LDPEDSRC 278 (339)
Q Consensus 271 lDP~dRrW 278 (339)
-||.|-|=
T Consensus 88 ~D~~d~r~ 95 (139)
T cd01215 88 RDSTDARA 95 (139)
T ss_pred cCCCCCeE
Confidence 99998763
No 22
>cd01271 Fe65_C Fe65 C-terminal Phosphotyrosine-binding (PTB) domain. Fe65 C-terminal Phosphotyrosine-binding (PTB) domain. Fe65 is an amyloid beta A4 precursor (APP) protein-binding. It contains an N-terminal WW domain followed by two PTB domains. The C-terminal PTB domain is responsible for APP binding. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=97.40 E-value=0.00039 Score=60.45 Aligned_cols=73 Identities=22% Similarity=0.335 Sum_probs=59.8
Q ss_pred cceeeeeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccc--cccccccccCCCceeeecCCC
Q psy10618 199 CNVLYLVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNK--RQLFFRRHYPVASISYCGLDP 273 (339)
Q Consensus 199 CnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnq--RKlFFRRHYp~n~v~fC~lDP 273 (339)
-.+.|||+++++.-+|-+.+..||..++++..+-.-..|++.|+..|||+.|.+ ..+.-. .++..|||||.|-
T Consensus 4 f~~~yLG~~~V~~p~Gmdvln~AI~~l~~~~~~~~w~~V~vsvaps~v~v~~~~~~~~~l~e--crVr~lSF~GvgK 78 (124)
T cd01271 4 FRVQYLGMLPVDKPTGMEILNSAIDNLMSSSNKEDWLSVNVNVAPSTITVISEKNEEEVLVE--CRVRYLSFLGIGK 78 (124)
T ss_pred EEEEEeccEeecCCccHHHHHHHHHHHHhcCCcccCceEEEEeCCceEEEEccCccceeeee--eeEEEeccccCCC
Confidence 357999999999999999999999999987766667789999999999999754 223222 5589999999974
No 23
>cd01270 DYC-1 DYC-1 (DYB-1 binding and Capon related) Phosphotyrosine-binding (PTB) domain. DYC-1 (DYB-1 binding and Capon related) Phosphotyrosine-binding (PTB) domain. DYC-1 contains an N-terminal PTB domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. The PTB domains of both SHC and IRS-1, for example, bind to a NPXpY sequence. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated; whereas, other PTB domains can bind motifs lacking tyrosine residues altogether.
Probab=97.22 E-value=0.00082 Score=59.49 Aligned_cols=83 Identities=17% Similarity=0.263 Sum_probs=60.6
Q ss_pred ccccceeeeeeeccCCccchHHHHHHHHhhhC---CCCCCCceEEEEEEecceeeeeccccc-----------ccccccc
Q psy10618 196 GAACNVLYLVSVDTESLTGPQAVTRAINSLFG---TKPLPHAAVVHFKVSSQGITLTDNKRQ-----------LFFRRHY 261 (339)
Q Consensus 196 gaaCnvlyL~sv~~esltG~~Av~kAv~~~l~---~~~~p~~tvVhFKVS~qGITLTDnqRK-----------lFFRRHY 261 (339)
|-..++=|||+++++.-.|.+-+..|+..+-. .... ...-|.+.||..||-++|...| ...=-..
T Consensus 2 GitF~vKYlG~~eV~~~~g~~~~~~A~rrir~~~ka~~~-Kk~kV~l~VS~~Gv~v~d~k~~~~~~~~~~~~tk~li~~~ 80 (140)
T cd01270 2 GITFEAKYVGSEEVPRPNTRAEIVAAMRRIRYEFKAQNI-KKRKVTIHVSVDGVKVVLKKKKRKKKNWTWDESKILVMNH 80 (140)
T ss_pred ceEEEEEEcceEEecCCCCcCHHHHHHHHHHHHHHHhCC-CceeEEEEEecCcEEEEecccccccccccccCcccEEEec
Confidence 55678899999999999998877777765431 1111 1234999999999999986422 1222355
Q ss_pred CCCceeeecCCCCCCccc
Q psy10618 262 PVASISYCGLDPEDSRCL 279 (339)
Q Consensus 262 p~n~v~fC~lDP~dRrW~ 279 (339)
|+..|+||+-||+|-+--
T Consensus 81 ~i~rISf~a~D~~~~k~F 98 (140)
T cd01270 81 PIYRIFYVSHDSQDLKIF 98 (140)
T ss_pred CeeEEEEeecCCCCCcEE
Confidence 999999999999988743
No 24
>KOG3775|consensus
Probab=96.87 E-value=0.00067 Score=68.56 Aligned_cols=113 Identities=22% Similarity=0.347 Sum_probs=81.4
Q ss_pred ccceeeeeeeccCCccchHHHHHHHHhhhCC----CCCCCceEEEEEEecceeeeeccccccccc----cc-cCCCceee
Q psy10618 198 ACNVLYLVSVDTESLTGPQAVTRAINSLFGT----KPLPHAAVVHFKVSSQGITLTDNKRQLFFR----RH-YPVASISY 268 (339)
Q Consensus 198 aCnvlyL~sv~~esltG~~Av~kAv~~~l~~----~~~p~~tvVhFKVS~qGITLTDnqRKlFFR----RH-Yp~n~v~f 268 (339)
...|-|||||+|--..|...+..||+++++. ....+|..+-+.+|-.||-+.+..|+.=|. +| |-..+|+|
T Consensus 338 rf~l~~LgSVEv~~HKGngVlcqAm~KI~t~ykns~~~~~p~s~~lEislRgV~~s~k~~~~~~k~~~c~~f~~lknisf 417 (482)
T KOG3775|consen 338 RFDLQFLGSVEVPCHKGNGVLCQAMQKIATAYKNSVHLRPPASCVLEISLRGVKLSLKGGGPEFKFQRCSHFFQLKNISF 417 (482)
T ss_pred heeeeeeeeeEeecccCccHHHHHHHHHHHHhcCCccccCcchhhhhhhcceeEeecCCCCccccccccceeeEecccce
Confidence 3567899999999999998888888887764 333467788899999999999999988644 34 56789999
Q ss_pred ecCCCCCCccccCCccccccccccchhHHHHhcCCCC--hhhhhccee
Q psy10618 269 CGLDPEDSRCLTRPWCISKSHCSCDKNFKSCLKSTKS--AAADVMGEF 314 (339)
Q Consensus 269 C~lDP~dRrW~~~~~~~~~s~C~cd~~F~~CLk~~~~--~~sn~vG~~ 314 (339)
|+-||.+.+|.-. +|+ |=.=.+-|..++|+... .++..||.+
T Consensus 418 c~~hpr~n~~~gf---itk-hp~~~rfachVfks~es~rpvA~sVgRa 461 (482)
T KOG3775|consen 418 CGCHPRNNCYFGF---ITK-HPLLSRFACHVFKSQESTRPVAESVGRA 461 (482)
T ss_pred eccccccceEEEe---ecc-chhhhheeeeeeecccCChHHHHHHHHH
Confidence 9999999999742 222 11112233344555443 356678876
No 25
>cd04706 PLA2_plant PLA2_plant: Plant-specific sub-family of Phospholipase A2, a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers. This sub-family does not appear to have a conserved active site and metal-binding loop.
Probab=96.77 E-value=0.00083 Score=57.92 Aligned_cols=35 Identities=34% Similarity=0.564 Sum_probs=27.1
Q ss_pred CccccCCCCCCCCccCCCCccccchhhccccCCcccc
Q psy10618 67 GTKWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKI 103 (339)
Q Consensus 67 GTkWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I 103 (339)
-.+|||+|+.+.. ++.---.+|+||+.||+|-+..
T Consensus 24 YG~yCG~g~~g~~--~~~P~D~lD~CC~~HD~Cy~~~ 58 (117)
T cd04706 24 YGKYCGPGYSGCP--GERPCDDLDACCMTHDACVQAK 58 (117)
T ss_pred cCcccCCCCCCCC--CCCCcchhhHHHHhCcCcccCC
Confidence 6799999997632 2334467899999999999754
No 26
>cd01209 SHC SHC phosphotyrosine-binding (PTB) domain. SHC phosphotyrosine-binding (PTB) domain. SHC is a substrate for receptor tyrosine kinases, which can interact with phosphoproteins at NPXY motifs. SHC contains an PTB domain followed by an SH2 domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=96.23 E-value=0.018 Score=52.22 Aligned_cols=90 Identities=18% Similarity=0.235 Sum_probs=67.8
Q ss_pred HHHHHhhccccceeeeeeeccCCc-------cchHHHHHHHHhhhCCCCCC-------------------CceEEEEEEe
Q psy10618 189 AQLLLAQGAACNVLYLVSVDTESL-------TGPQAVTRAINSLFGTKPLP-------------------HAAVVHFKVS 242 (339)
Q Consensus 189 ~~~ll~~gaaCnvlyL~sv~~esl-------tG~~Av~kAv~~~l~~~~~p-------------------~~tvVhFKVS 242 (339)
...|+..|-...|-|||++++..= ++-+-++.||+.+-+..+.. ..+.|.+.||
T Consensus 3 ~~~l~~~GV~y~vrYlG~~eV~~Smr~~~~~~Rtqv~rEaI~rV~ea~~~~~~~~~~~~~~~~~~~~~~~~~~~V~l~IS 82 (160)
T cd01209 3 DDKVMGPGVSYLVRYMGCVEVLQSMRALDFETRTQVTRECISLVCEAVGGAKAATERNLNSILGRSNLKFAGMPITINVS 82 (160)
T ss_pred HHHhhcCCcEEEEEEeeEEeehhhcccCCcchhHHHHHHHHHHHHhccccccccccccccccccCccccccCceEEEEEE
Confidence 356888899999999999999943 88888999998886542221 2467999999
Q ss_pred cceeeeeccccccccccccCCCceeeecC-CCCCCccc
Q psy10618 243 SQGITLTDNKRQLFFRRHYPVASISYCGL-DPEDSRCL 279 (339)
Q Consensus 243 ~qGITLTDnqRKlFFRRHYp~n~v~fC~l-DP~dRrW~ 279 (339)
.+||.+.|..-|--.- +.|..+||||+= ||+.-+|-
T Consensus 83 ~~~v~~~~~~t~~ii~-~H~l~~ISfaa~gd~d~~~~~ 119 (160)
T cd01209 83 SSSLNLMAQDCKQIIA-NHHMQSISFASGGDPDTAEYV 119 (160)
T ss_pred eeEEEEeccCchhHHh-cCCCcceEEEeCCCCCcceeE
Confidence 9999999875433222 569999999994 77664443
No 27
>cd00173 SH2 Src homology 2 domains; Signal transduction, involved in recognition of phosphorylated tyrosine (pTyr). SH2 domains typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.
Probab=94.76 E-value=0.012 Score=45.82 Aligned_cols=47 Identities=34% Similarity=0.462 Sum_probs=40.6
Q ss_pred hhhhhccccCCCCceeccCCCCCCCCchhhheecccccc--ccccccccCC
Q psy10618 123 LVRHFLIEPTPRGVRLKGCSNEPVFSSLSALVYQHSVLP--LALPCRLSLP 171 (339)
Q Consensus 123 lvrHfLIe~~~~gv~lkGc~~Ep~F~Slsalv~qhsi~~--laLPC~L~iP 171 (339)
-++||+|+....|..+.. .+..|+|+.+||.+|+.++ ..++|.|..|
T Consensus 45 ~v~H~~I~~~~~~~~~~~--~~~~f~sl~eLv~~y~~~~~~~~~~~~L~~p 93 (94)
T cd00173 45 KVKHYRIERTDDGYYLLG--EGRSFPSLPELIEHYQKNPLSDGLGVKLRYP 93 (94)
T ss_pred EEEEEEEEECCCCeEEec--CCCccCCHHHHHHHHhhCccCCCcccEeCCc
Confidence 578999999999888877 5568999999999999998 6888888776
No 28
>cd04707 otoconin_90 otoconin_90: Phospholipase A2-like domains present in otoconin-90 and otoconin-95, mammal proteins that are principal matrix proteins of calcitic otoconia. Interactions involving otoconin-90 may trigger or constitute key events in otoconia formation. The PLA2-like domains in otoconins may have lost their metal-binding sites.
Probab=93.58 E-value=0.025 Score=48.76 Aligned_cols=30 Identities=27% Similarity=0.595 Sum_probs=22.6
Q ss_pred cccCCCCCCCCccCCCCccccchhhccccCCccccc
Q psy10618 69 KWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIR 104 (339)
Q Consensus 69 kWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~ 104 (339)
-|||.|..-..-+ .+|+||..||.|=....
T Consensus 22 CyCG~GG~G~PvD------~~DrCC~~HD~CY~~~~ 51 (117)
T cd04707 22 CYCGQEGEGLPVD------ELDRCCFQHRCCLEQAS 51 (117)
T ss_pred CcccCCCCCCCcc------cchhHHHHhHHHHhhhh
Confidence 5899887543222 78999999999987554
No 29
>cd00125 PLA2c PLA2c: Phospholipase A2, a family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids (PC or phosphatidylethanolamine), usually in a metal-dependent reaction, to generate lysophospholipid (LysoPL) and a free fatty acid (FA). The resulting products are either dietary or used in synthetic pathways for leukotrienes and prostaglandins. Often, arachidonic acid is released as a free fatty acid and acts as second messenger in signaling networks. Secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis (LysoPL and FA) cannot form bilayers leading to a change in membrane conformation and ultimately to a block in
Probab=93.19 E-value=0.029 Score=48.08 Aligned_cols=31 Identities=29% Similarity=0.743 Sum_probs=23.4
Q ss_pred cccCCCCCCCCccCCCCccccchhhccccCCcccccc
Q psy10618 69 KWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIRA 105 (339)
Q Consensus 69 kWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~~ 105 (339)
-|||.|..-..=+ .+|+||+.||.|=..+..
T Consensus 25 CyCG~GG~G~PvD------~~DrCC~~HD~CY~~~~~ 55 (115)
T cd00125 25 CYCGLGGSGTPVD------DTDRCCQVHDCCYDRAEK 55 (115)
T ss_pred CccCCCCCCCCcc------cHHHHHHHHHhHHhcccc
Confidence 5899887543322 679999999999887653
No 30
>PF08398 Parvo_coat_N: Parvovirus coat protein VP1; InterPro: IPR013607 Parvoviruses are some of the smallest viruses containing linear, non-segmented single-stranded DNA genomes, with an average genome size of 5000 nucleotides. Parvoviruses have been described that infect a wide range of invertebrates and vertebrates and are well known for causing enteric disease in mammals. Genomes contains two large ORFs: NS1 and VP1; other ORFs are found in some sub-types and different gene products can arise from splice variants and the use of different start codons []. This is the N-terminal region of the Parvovirus VP1 coat protein []; its function is not known. ; GO: 0005198 structural molecule activity, 0019028 viral capsid
Probab=93.04 E-value=0.045 Score=42.92 Aligned_cols=48 Identities=27% Similarity=0.398 Sum_probs=34.3
Q ss_pred cCCccccCCCCCCCCccCCCCccccchhhccccCCccc-cccCcccccccCC
Q psy10618 65 IPGTKWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSK-IRAHTNRYNITND 115 (339)
Q Consensus 65 ~PGTkWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~-I~~~~~kygLtN~ 115 (339)
+||.+++||||.-.+-... ..+|..||+||.+=+. |..+..-|=-.|.
T Consensus 1 lPg~~YlGPgn~l~~g~Pv---~~~D~aA~~HD~aY~~~lk~G~NPY~~~n~ 49 (64)
T PF08398_consen 1 LPGYKYLGPGNPLDNGEPV---NPVDAAAREHDEAYDELLKHGDNPYLHFNH 49 (64)
T ss_pred CCCCCccCCCCCcCCCCCC---CHHHHHHHHHHHHHHHHHHcCCCCceeccH
Confidence 5999999999986555543 4789999999986544 5555554444443
No 31
>KOG3537|consensus
Probab=92.60 E-value=0.23 Score=51.66 Aligned_cols=118 Identities=25% Similarity=0.382 Sum_probs=82.4
Q ss_pred cceeeeeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeecCCC-----
Q psy10618 199 CNVLYLVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDP----- 273 (339)
Q Consensus 199 CnvlyL~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP----- 273 (339)
.+|=|||.||++---|-+.-.-|+..+-...-.|+-.| +-||+.|+.+.|-.-|-..- ---+.-|+||+=|-
T Consensus 39 F~VkYLG~VEV~ESRGM~vCE~AlK~Lkas~rk~Vkav--L~VS~DGLRVVD~~tk~LiV-DQTIEKVSFCAPDRn~Dr~ 115 (543)
T KOG3537|consen 39 FPVKYLGHVEVFESRGMQVCEDALKVLKASRRKPVKAV--LWVSGDGLRVVDDKTKGLIV-DQTIEKVSFCAPDRNHDRG 115 (543)
T ss_pred eeeeeeeeEEEecccCcHHHHHHHHHHHHhccCcceeE--EEEccCceEEeccCccceee-eeeeeeeeccccccccccc
Confidence 36799999999999999888888888776655454444 56999999999876554332 12345677887554
Q ss_pred --------CCCccccCCccccc------cccccchhHHHHh-cCCCChhhhhccee-eeeeeccc
Q psy10618 274 --------EDSRCLTRPWCISK------SHCSCDKNFKSCL-KSTKSAAADVMGEF-YFNIFRVP 322 (339)
Q Consensus 274 --------~dRrW~~~~~~~~~------s~C~cd~~F~~CL-k~~~~~~sn~vG~~-YFnvl~~~ 322 (339)
-.|||.--||+..+ || .=...|--|| |++.- +.-||.+ ||.-..+.
T Consensus 116 FsYICRDGttRRW~CH~FlA~KdsGERLSH-AVGCAFa~CLErKqRR--dkEcGvt~~fda~~st 177 (543)
T KOG3537|consen 116 FSYICRDGTTRRWMCHGFLACKDSGERLSH-AVGCAFAACLERKQRR--DKECGVTATFDASRST 177 (543)
T ss_pred eeEEeecCCcceeeeeeeeeecchhhHHHH-HHHHHHHHHHHHHhhh--hhhccceeeeeccccc
Confidence 46888887776643 33 2345899998 55544 5568877 88776654
No 32
>cd01208 X11 X11 Phosphotyrosine-binding (PTB) domain. X11 Phosphotyrosine-binding (PTB) domain. The neuronal protein X11 has a PTB domain followed by two PDZ domains. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether. X11 binds to the cytoplasmic domain of the beta-amyloid precursor protein (beta-APP) and does not require the substrate to be tyrosine-phosphorylated for binding.
Probab=92.47 E-value=0.44 Score=43.22 Aligned_cols=78 Identities=21% Similarity=0.222 Sum_probs=56.0
Q ss_pred ccccceeeeeeec-cCCccchHHHH-----HHHHhhhCCCCCC-CceEEEEEEecceeeeeccccccccccccCCCceee
Q psy10618 196 GAACNVLYLVSVD-TESLTGPQAVT-----RAINSLFGTKPLP-HAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISY 268 (339)
Q Consensus 196 gaaCnvlyL~sv~-~esltG~~Av~-----kAv~~~l~~~~~p-~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~f 268 (339)
|-...+=||||.. +-+.++.-+.+ .||+.+-+.+... ..+.|-+.||-+||.+-|..-|--. -.+|+.+|+|
T Consensus 4 Gv~f~a~YlG~t~~~~~~~~~~~tR~~~a~Eai~rik~~eG~~~~~t~V~L~IS~~gV~v~~~~tk~im-~~h~L~~ISy 82 (156)
T cd01208 4 GVLFRARYLGSTQLLCEKTPSKNVRMXQAQEAVSRIKAPEGESQPSTEVDLFISTEKIMVLNTDLQEIX-MDHALRTISY 82 (156)
T ss_pred ceEEEEEeeceeeeeecCCCChhhhHHHHHHHHHHHhccccCCCCCcEEEEEEEeCeEEEEecCcccee-ccCcccceEE
Confidence 5556778999987 33355555555 6888887543222 3568999999999999877554433 2679999999
Q ss_pred ecCCCCC
Q psy10618 269 CGLDPED 275 (339)
Q Consensus 269 C~lDP~d 275 (339)
|+ |..|
T Consensus 83 ~A-D~~d 88 (156)
T cd01208 83 IA-DIGD 88 (156)
T ss_pred Ee-cCCC
Confidence 98 8765
No 33
>cd01217 CG12581 CG12581 Phosphotyrosine-binding (PTB) domain. CG12581 Phosphotyrosine-binding (PTB) domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=91.15 E-value=0.5 Score=42.77 Aligned_cols=74 Identities=22% Similarity=0.370 Sum_probs=53.3
Q ss_pred ccceeeeeeec-cCCccchHHHHHHHHhhhCCCCC--CCceEEEEEEecceeeeecccccc-ccccccCCCceeeecC
Q psy10618 198 ACNVLYLVSVD-TESLTGPQAVTRAINSLFGTKPL--PHAAVVHFKVSSQGITLTDNKRQL-FFRRHYPVASISYCGL 271 (339)
Q Consensus 198 aCnvlyL~sv~-~esltG~~Av~kAv~~~l~~~~~--p~~tvVhFKVS~qGITLTDnqRKl-FFRRHYp~n~v~fC~l 271 (339)
.|.|+||||+. ...-+|-+++|.-+++++..+.. -...-=-+.|+++|+.|--..-+. .=-+-||..+|-||+-
T Consensus 3 ~f~V~yLGS~pl~dk~~sLqgiQEPLr~LY~se~~~~kKl~~gsL~Ics~GLrvk~s~~~~~~E~~~fP~~~i~~~aA 80 (158)
T cd01217 3 RCRVLYLGSLVPKDKKDGLQGIQEPLRQLYPSEVTPKKKGIDSWLSVWSNGLLLEISALAEKNETLFFPIHNLHYCAA 80 (158)
T ss_pred eEEEEEEcCcCCccccchhhhhhhHHHHhhhhccccccccccceEEEecCceEEEeccccccccccccccceeeEeeE
Confidence 48899999977 77889999999999999844322 233345678888998886432221 1124689999999986
No 34
>cd01211 GAPCenA GAPCenA Phosphotyrosine-binding (PTB) domain. GAPCenA Phosphotyrosine-binding (PTB) domain. GAPCenA is a centrosome-associated GTPase activating protein (GAP) for rab 6. It consists of an N-terminal PTB domain and a C-terminal TBC domain. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=90.68 E-value=0.75 Score=40.39 Aligned_cols=89 Identities=16% Similarity=0.214 Sum_probs=63.9
Q ss_pred ceeeeeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEe--cce-eeeeccccccccccccCCCceeeecCCCCCC
Q psy10618 200 NVLYLVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVS--SQG-ITLTDNKRQLFFRRHYPVASISYCGLDPEDS 276 (339)
Q Consensus 200 nvlyL~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS--~qG-ITLTDnqRKlFFRRHYp~n~v~fC~lDP~dR 276 (339)
||-|||.--++.--++.-++++|..+-++... .+-.|.+.|. ++| |.|+|-+-+-= =-|||+..|+||+--|.|.
T Consensus 5 ~vtYLGct~V~aP~sE~e~~r~m~~l~~~s~~-~~i~Vtl~Vp~~seG~V~l~D~~t~~~-ias~~I~rI~fC~rG~~~t 82 (125)
T cd01211 5 NVTYLGCSQLVNPDSENEMKRLMKVLDEQSGA-QTINVTLVVPNNIEGTVKLIDAQSNKV-IASFSIVNIRFCIRGESST 82 (125)
T ss_pred CcEEeeeEEecCCCCHHHHHHHHHHHHhhccc-CCeEEEEEecCCCCceEEEEcCCCCcE-EEEEEEEEEEEEEecCCCC
Confidence 68899999999999999889999877655432 1445555555 555 99999876432 2599999999999966665
Q ss_pred ccccCCccccccccc
Q psy10618 277 RCLTRPWCISKSHCS 291 (339)
Q Consensus 277 rW~~~~~~~~~s~C~ 291 (339)
.=++ -+-|+-+|..
T Consensus 83 ~e~~-cFAft~s~~~ 96 (125)
T cd01211 83 SENN-CFAFTFTHKI 96 (125)
T ss_pred cccc-cEEEEeecCC
Confidence 4333 3445555554
No 35
>KOG4087|consensus
Probab=79.13 E-value=0.77 Score=41.15 Aligned_cols=30 Identities=30% Similarity=0.782 Sum_probs=21.9
Q ss_pred cccCCCCCCCCccCCCCccccchhhccccCCccccc
Q psy10618 69 KWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIR 104 (339)
Q Consensus 69 kWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~ 104 (339)
=|||-|-.-..- -.+|+||-.||.|=+-.+
T Consensus 46 CyCGlGG~G~P~------D~iDwCC~~HDcCY~~le 75 (144)
T KOG4087|consen 46 CYCGLGGSGQPK------DAIDWCCHAHDCCYDRLE 75 (144)
T ss_pred ccccCCCCCCcc------chHHHHHhcccHHHHHHH
Confidence 478877654433 368999999999977544
No 36
>KOG3536|consensus
Probab=76.73 E-value=2.4 Score=42.40 Aligned_cols=93 Identities=25% Similarity=0.380 Sum_probs=65.3
Q ss_pred CCCchHHHHHhhc-cccceeeeeeeccCCccchHHHHHHHHhhhCCCC-----CCCceEEEEEEecceeeeecccccccc
Q psy10618 184 PSITSAQLLLAQG-AACNVLYLVSVDTESLTGPQAVTRAINSLFGTKP-----LPHAAVVHFKVSSQGITLTDNKRQLFF 257 (339)
Q Consensus 184 ~~~~~~~~ll~~g-aaCnvlyL~sv~~esltG~~Av~kAv~~~l~~~~-----~p~~tvVhFKVS~qGITLTDnqRKlFF 257 (339)
..|....+-|-.| .+.++.|||..++|.-.|...++-|+..+--.++ --.-..|..+||-|||-|+|+--+- -
T Consensus 33 ~~w~~t~e~l~~g~v~y~~kflg~~ev~qpkG~~vv~~a~r~~rr~~~~kkseg~k~~kvE~~Isi~gviI~~~~T~~-v 111 (321)
T KOG3536|consen 33 ENWTHTRETLIEGHVPYSAKFLGMTEVEQPKGTDVVREAIRAIRRTNPFKKSEGEKLQKVELSISIQGVIIRDLGTMA-V 111 (321)
T ss_pred cccccchhhhhcccHHHHHHhcccccccCCCccHHHHHHHHhhhhcccccccccccccceeeeeccceeEEeeccccc-c
Confidence 3444444444455 8899999999999999999777666655532222 1234479999999999999875433 2
Q ss_pred ccccCCCceeeecCCCCCCc
Q psy10618 258 RRHYPVASISYCGLDPEDSR 277 (339)
Q Consensus 258 RRHYp~n~v~fC~lDP~dRr 277 (339)
.-.+|+..|+||.=|-.+.|
T Consensus 112 ~~~~~l~rIs~caddk~~kR 131 (321)
T KOG3536|consen 112 KHNFPLYRISYCADDKLAKR 131 (321)
T ss_pred eecCChhhhhHhHhHHHHHH
Confidence 34578899999987755444
No 37
>smart00252 SH2 Src homology 2 domains. Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae.
Probab=76.63 E-value=0.91 Score=34.94 Aligned_cols=37 Identities=30% Similarity=0.330 Sum_probs=29.4
Q ss_pred hhhhhccccCC-CCceeccCCCCCCCCchhhheeccccccc
Q psy10618 123 LVRHFLIEPTP-RGVRLKGCSNEPVFSSLSALVYQHSVLPL 162 (339)
Q Consensus 123 lvrHfLIe~~~-~gv~lkGc~~Ep~F~Slsalv~qhsi~~l 162 (339)
.++||+|+... .+..|.+ +..|+|+.+||.+++.+++
T Consensus 46 ~~~h~~I~~~~~~~~~l~~---~~~F~sl~eLI~~y~~~~~ 83 (84)
T smart00252 46 KVKHYRIRRNEDGKFYLDG---GRKFPSLVELVEHYQKNSL 83 (84)
T ss_pred EEEEEEEEECCCCcEEECC---CCccCCHHHHHHHHhhCCC
Confidence 47899999887 5677766 5579999999988877654
No 38
>PF00068 Phospholip_A2_1: Phospholipase A2; InterPro: IPR001211 Phospholipase A2 (3.1.1.4 from EC) (PLA2) is a small lipolytic enzyme that releases fatty acids from the second carbon group of glycerol. It is involved in a number of physiologically important cellular processes, such as the liberation of arachidonic acid from membrane phospholipids []. It plays a pivotal role in the biosynthesis of prostaglandin and other mediators of inflammation. PLA2 has four to seven disulphide bonds and binds a calcium ion that is essential for activity. Within the active enzyme, the alpha amino group is involved in a conserved hydrogen-bonding network linking the N-terminal region to the active site. The side chains of two conserved residues, His and Asp, participate in the catalytic network. Many PLA2's are widely distributed in snakes, lizards, bees and mammals. In mammals there are at least four forms: pancreatic, membrane-associated as well as two less well characterised forms. The venom of most snakes contains multiple forms of PLA2. Some of them are presynaptic neurotoxins which inhibit neuromuscular transmission by blocking acetylcholine release from the nerve termini. Some of the proteins in this family are allergens. Allergies are hypersensitivity reactions of the immune system to specific substances called allergens (such as pollen, stings, drugs, or food) that, in most people, result in no symptoms. A nomenclature system has been established for antigens (allergens) that cause IgE-mediated atopic allergies in humans [WHO/IUIS Allergen Nomenclature Subcommittee King T.P., Hoffmann D., Loewenstein H., Marsh D.G., Platts-Mills T.A.E., Thomas W. Bull. World Health Organ. 72:797-806(1994)]. This nomenclature system is defined by a designation that is composed of the first three letters of the genus; a space; the first letter of the species name; a space and an arabic number. In the event that two species names have identical designations, they are discriminated from one another by adding one or more letters (as necessary) to each species designation. The allergens in this family include allergens with the following designations: Api m 1.; GO: 0004623 phospholipase A2 activity, 0005509 calcium ion binding, 0016042 lipid catabolic process; PDB: 1OQS_F 1S6B_B 1XXW_B 1MH2_B 2RD4_B 1OZ6_A 2OSN_A 2PH4_B 1FDK_A 2BP2_A ....
Probab=75.84 E-value=0.57 Score=39.80 Aligned_cols=31 Identities=32% Similarity=0.790 Sum_probs=20.8
Q ss_pred cccCCCCCCCCccCCCCccccchhhccccCCcccccc
Q psy10618 69 KWCGTGDIADTYFDLGSEIKLDKCCRTHDLCPSKIRA 105 (339)
Q Consensus 69 kWCG~Gn~A~~y~dLG~~~~tD~CCR~HD~C~~~I~~ 105 (339)
-|||.|..-.. --.+|+||+.||.|-.-+..
T Consensus 26 CyCg~~g~G~P------vD~iD~~C~~h~~Cy~~~~~ 56 (116)
T PF00068_consen 26 CYCGFGGKGQP------VDEIDRCCRKHDQCYKCAKE 56 (116)
T ss_dssp TTBSSSSSSS-------SSHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCCCCCC------cccccchhHHhHHHHHHHhc
Confidence 38887753221 23589999999999765543
No 39
>cd01269 PLX Pollux (PLX) Phosphotyrosine-binding (PTB) domain. Pollux (PLX) Phosphotyrosine-binding (PTB) domain. PLX is calmodulin-binding protein containing a TBC domain, which is conserved from yeast to man, but it only has an N-terminal PTB domain in mammals. PTB domains have a PH-like fold and are found in various eukaryotic signaling molecules. They were initially identified based upon their ability to recognize phosphorylated tyrosine residues. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. More recent studies have found that some types of PTB domains can bind to peptides which are not tyrosine phosphorylated or lack tyrosine residues altogether.
Probab=70.45 E-value=12 Score=33.11 Aligned_cols=77 Identities=18% Similarity=0.226 Sum_probs=55.3
Q ss_pred cceeeeeeeccCCccchH-HHHHHHHhhhC--CCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCC
Q psy10618 199 CNVLYLVSVDTESLTGPQ-AVTRAINSLFG--TKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPED 275 (339)
Q Consensus 199 CnvlyL~sv~~esltG~~-Av~kAv~~~l~--~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~d 275 (339)
..|||-|-|-+..-..|. .|..||.+.-- ..-......+-|-|+..||.|+|..+|.-+-.| +...|++|+-|-++
T Consensus 4 ~~~~~~~~~~~~~~~~~~~li~e~I~K~~~~~~~kr~~nrtm~~~I~~~~v~lispdtK~vl~~k-~f~dISsC~qg~~~ 82 (129)
T cd01269 4 FEVLYCGRVTVTHKKAPSSLIDDCIEKFSLHEQQRLKDNRTMLFQVGRFEINLISPDTKSVVLEK-NFKDISSCSQGIKH 82 (129)
T ss_pred eEEEEEeeEEEeeccCChHHHHHHHHHhhhhhhhhccCCcEEEEEEeccceEEEcCCcceEEEec-CccccchhhcCCCC
Confidence 357888888887777766 45666665421 122223556999999999999999999866554 66789999988664
Q ss_pred C
Q psy10618 276 S 276 (339)
Q Consensus 276 R 276 (339)
-
T Consensus 83 ~ 83 (129)
T cd01269 83 V 83 (129)
T ss_pred c
Confidence 3
No 40
>PF00017 SH2: SH2 domain; InterPro: IPR000980 The Src homology 2 (SH2) domain is a protein domain of about 100 amino-acid residues first identified as a conserved sequence region between the oncoproteins Src and Fps []. Similar sequences were later found in many other intracellular signal-transducing proteins []. SH2 domains function as regulatory modules of intracellular signalling cascades by interacting with high affinity to phosphotyrosine-containing target peptides in a sequence-specific, SH2 domains recognise between 3-6 residues C-terminal to the phosphorylated tyrosine in a fashion that differs from one SH2 domain to another, and strictly phosphorylation-dependent manner [, , , ]. They are found in a wide variety of protein contexts e.g., in association with catalytic domains of phospholipase Cy (PLCy) and the non-receptor protein tyrosine kinases; within structural proteins such as fodrin and tensin; and in a group of small adaptor molecules, i.e Crk and Nck. The domains are frequently found as repeats in a single protein sequence and will then often bind both mono- and di-phosphorylated substrates. The structure of the SH2 domain belongs to the alpha+beta class, its overall shape forming a compact flattened hemisphere. The core structural elements comprise a central hydrophobic anti-parallel beta-sheet, flanked by 2 short alpha-helices. The loop between strands 2 and 3 provides many of the binding interactions with the phosphate group of its phosphopeptide ligand, and is hence designated the phosphate binding loop, the phosphorylated ligand binds perpendicular to the beta-sheet and typically interacts with the phosphate binding loop and a hydrophobic binding pocket that interacts with a pY+3 side chain. The N- and C-termini of the domain are close together in space and on the opposite face from the phosphopeptide binding surface and it has been speculated that this has facilitated their integration into surface-exposed regions of host proteins [].; GO: 0005515 protein binding; PDB: 1M27_A 1KA6_A 1D4W_B 1D4T_A 1D1Z_B 1KA7_A 1UUR_A 1UUS_A 1BLJ_A 1BLK_A ....
Probab=69.18 E-value=1.3 Score=33.54 Aligned_cols=32 Identities=41% Similarity=0.478 Sum_probs=24.4
Q ss_pred hhhhhccccCCCC-ceeccCCCCCCCCchhhheecc
Q psy10618 123 LVRHFLIEPTPRG-VRLKGCSNEPVFSSLSALVYQH 157 (339)
Q Consensus 123 lvrHfLIe~~~~g-v~lkGc~~Ep~F~Slsalv~qh 157 (339)
-|+||+|+...+| ..+. ....|+||++||.++
T Consensus 45 ~v~h~~I~~~~~~~~~~~---~~~~F~sl~~LV~~y 77 (77)
T PF00017_consen 45 KVKHFRINRTENGGYFLS---DGKKFPSLSDLVEHY 77 (77)
T ss_dssp EEEEEEEEEETTSEEESS---TSSEBSSHHHHHHHH
T ss_pred ccEEEEEEecCCceEEcc---CCCcCCCHHHHHHhC
Confidence 5789999999998 3332 344699999999764
No 41
>cd00618 PLA2_like PLA2_like: Phospholipase A2, a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids (PC or phosphatidylethanolamine), usually in a metal-dependent reaction, to generate lysophospholipid (LysoPL) and a free fatty acid (FA). The resulting products are either dietary or used in synthetic pathways for leukotrienes and prostaglandins. Often, arachidonic acid is released as a free fatty acid and acts as second messenger in signaling networks. Secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis (LysoPL and FA) cannot form bilayers leading to a change in membrane conformation and ultimately
Probab=67.86 E-value=2.4 Score=33.11 Aligned_cols=18 Identities=39% Similarity=1.058 Sum_probs=15.8
Q ss_pred ccccccccchhHHHHhcC
Q psy10618 285 ISKSHCSCDKNFKSCLKS 302 (339)
Q Consensus 285 ~~~s~C~cd~~F~~CLk~ 302 (339)
.++++|+||++|..||++
T Consensus 65 c~~~~C~CD~~~a~Cl~~ 82 (83)
T cd00618 65 CTRSHCDCDRRLAICLAR 82 (83)
T ss_pred hhHhhCcccHHHHHHhhh
Confidence 457899999999999975
No 42
>smart00085 PA2c Phospholipase A2.
Probab=58.35 E-value=2 Score=36.68 Aligned_cols=45 Identities=22% Similarity=0.324 Sum_probs=37.1
Q ss_pred ccccccccchhHHHHhcCCCChhhhhcceeeeeeeccceeeeCCCCCc
Q psy10618 285 ISKSHCSCDKNFKSCLKSTKSAAADVMGEFYFNIFRVPCIIDTPSGKK 332 (339)
Q Consensus 285 ~~~s~C~cd~~F~~CLk~~~~~~sn~vG~~YFnvl~~~Cf~~~~~~~~ 332 (339)
+++++|+|++.|..|+.+ ++ +..++.-+|+...+.||+..+-..+
T Consensus 63 ~~~y~~~c~~~~~~C~~~-~~--~C~~~~C~CD~~aa~Cf~~~~yn~~ 107 (117)
T smart00085 63 TTTYSYSCDNGFITCGGK-NT--ACLVFVCECDRAAAICFAKNPYNKK 107 (117)
T ss_pred ccceEEEEECCcceECcC-CC--ccceeecccCHHHHHHhhhCccChh
Confidence 567899999999999865 33 6668888999999999998876555
No 43
>PF00357 Integrin_alpha: Integrin alpha cytoplasmic region; InterPro: IPR018184 Some alpha subunits are cleaved post- translationally to produce a heavy and a light chain linked by a disulphide bond [, ]. Integrin alpha chains share a conserved sequence which is found at the beginning of the cytoplasmic domain, just after the end of the transmembrane region. Within the N-terminal domain of alpha subunits, seven sequence repeats, each of approximately 60 amino acids, have been found []. It has been predicted that these repeats assume the beta-propeller fold. The domains contain seven four-stranded beta-sheets arranged in a torus around a pseudosymmetry axis []. Integrin ligands and a putative Mg2+ ion are predicted to bind to the upper face of the propeller, in a manner analogous to the way in which the trimeric G-protein beta subunit (G beta) (which also has a beta-propeller fold) binds the G protein alpha subunit []. Integrin cytoplasmic domains are normally less than 50 amino acids in length, with the beta-subunit sequences exhibiting greater homology to each other than the alpha-subunit sequences []. This is consistent with current evidence that the beta subunit is the principal site for binding of cytoskeletal and signalling molecules, whereas the alpha subunit has a regulatory role. The first ten residues of the alpha-subunit cytoplasmic domain appear to form an alpha helix that is terminated by a proline residue. The remainder of the domain is highly acidic in nature and this loops back to contact the membrane-proximal lysine anchor residue. This entry represents the conserved site of the C-terminal integrin alpha chain. ; PDB: 2LKJ_A 2LKE_A 2K8O_A 1DPK_A 2K9J_A 1DPQ_A 1S4W_A 1M8O_A 2K1A_A 2KNC_A ....
Probab=53.58 E-value=2.1 Score=24.89 Aligned_cols=8 Identities=50% Similarity=1.107 Sum_probs=7.1
Q ss_pred ccccccCC
Q psy10618 256 FFRRHYPV 263 (339)
Q Consensus 256 FFRRHYp~ 263 (339)
||.|.||.
T Consensus 4 FFKR~~~~ 11 (15)
T PF00357_consen 4 FFKRQRPP 11 (15)
T ss_dssp HHHHHHHH
T ss_pred cccccCcc
Confidence 99999985
No 44
>KOG4448|consensus
Probab=52.80 E-value=12 Score=38.07 Aligned_cols=93 Identities=20% Similarity=0.310 Sum_probs=69.2
Q ss_pred ccceeeeeeeccCCccchHHHHHHHHhhhCCCC-C-CCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCC
Q psy10618 198 ACNVLYLVSVDTESLTGPQAVTRAINSLFGTKP-L-PHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPED 275 (339)
Q Consensus 198 aCnvlyL~sv~~esltG~~Av~kAv~~~l~~~~-~-p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~d 275 (339)
..+|+|||.+=+-.-+|+....|+++.+-.... . -.-++..+||+.+|+-.+-.|--+= -|=++-|+||.-|+.-
T Consensus 62 ~y~V~ylgnalti~argegc~ek~ls~iw~~~t~~~r~~~~M~Lkv~asglk~~h~qe~l~---ly~ahrityc~a~~~~ 138 (374)
T KOG4448|consen 62 PYVVFYLGNALTICARGEGCKEKTLSGIWHFYTMLKRKDNVMTLKVEASGLKAFHEQEGLT---LYWAHRITYCRAPSGY 138 (374)
T ss_pred CeEEEEecceeEEEecCCCcchhhhhhHHHHHHhhcccCceeEEEEecccceeeeccCcce---eeeeeeeeeeecCCCC
Confidence 478999999999999999999999887744211 1 1356889999999999988877652 3778889999999874
Q ss_pred CccccCCccc------cccccccchh
Q psy10618 276 SRCLTRPWCI------SKSHCSCDKN 295 (339)
Q Consensus 276 RrW~~~~~~~------~~s~C~cd~~ 295 (339)
-| .+-|+| -++.|+|.-+
T Consensus 139 pk--vf~wiyrhegk~~~~~lrchaV 162 (374)
T KOG4448|consen 139 PK--VFCWIYRHEGKQLKSELRCHAV 162 (374)
T ss_pred Ce--EEEEEEecchhhhhhccceeee
Confidence 43 234555 2466777644
No 45
>PF10480 ICAP-1_inte_bdg: Beta-1 integrin binding protein; InterPro: IPR019517 ICAP-1 is a serine/threonine-rich protein that binds to the cytoplasmic domains of beta-1 integrins in a highly specific manner, binding to a NPXY sequence motif on the beta-1 integrin. The cytoplasmic domains of integrins are essential for cell adhesion, and the fact that phosphorylation of ICAP-1 by interaction with the cell-matrix implies an important role of ICAP-1 during integrin-dependent cell adhesion []. Over expression of ICAP-1 strongly reduces the integrin-mediated cell spreading on extracellular matrix and inhibits both Cdc42 and Rac1. In addition, ICAP-1 induces release of Cdc42 from cellular membranes and prevents the dissociation of GDP from this GTPase []. An additional function of ICAP-1 is to promote differentiation of osteoprogenitors by supporting their condensation through modulating the integrin high affinity state [].
Probab=50.09 E-value=87 Score=29.75 Aligned_cols=70 Identities=33% Similarity=0.476 Sum_probs=50.3
Q ss_pred cccceeeeeeeccC------CccchHHHHHHHHhhhCCCCCC---CceEEEEEEecceeeeeccccccccccccCCCcee
Q psy10618 197 AACNVLYLVSVDTE------SLTGPQAVTRAINSLFGTKPLP---HAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASIS 267 (339)
Q Consensus 197 aaCnvlyL~sv~~e------sltG~~Av~kAv~~~l~~~~~p---~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~ 267 (339)
|-..|=|||.++.- +|.||.=+-++|...=....+| .-..|-+-||.-||-+||+.+..-.-|| |+..|.
T Consensus 61 ~ef~Vkyvg~i~~l~~~~~~~le~pl~lI~~ID~aQq~GkLP~v~~~eevil~VSKyGiKvt~~d~~~VL~Rh-pL~~Iv 139 (200)
T PF10480_consen 61 AEFRVKYVGAIESLQFSMSKSLEGPLELINYIDSAQQDGKLPFVPSDEEVILSVSKYGIKVTDNDQRDVLHRH-PLHEIV 139 (200)
T ss_pred hheeeeeeeehhhcccccccccccHHHHHHHHHHHhhcCcCCCCCCCCeEEEEEeeccEEEeecCCcceeeee-eeeeEE
Confidence 34678899998754 3788887778877664444444 1235669999999999999988877786 444443
No 46
>PF11663 Toxin_YhaV: Toxin with endonuclease activity YhaV; InterPro: IPR021679 YhaV causes reversible bacteriostasis and is part of a toxin-antitoxin system in Escherichia coli along with PrlF. The toxicity of YhaV is counteracted by PrlF by the formation of a tight complex which binds to the promoter of the prlF-yhaV operon. In vitro, YhaV also has endonuclease activity [].
Probab=42.78 E-value=36 Score=30.63 Aligned_cols=77 Identities=23% Similarity=0.293 Sum_probs=56.7
Q ss_pred HHHHHHHHhhhCCCCCCCceEEEEEEecceeeeec-----------cccccccccccCCCceeeecCCCCCCccccCCcc
Q psy10618 216 QAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTD-----------NKRQLFFRRHYPVASISYCGLDPEDSRCLTRPWC 284 (339)
Q Consensus 216 ~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTD-----------nqRKlFFRRHYp~n~v~fC~lDP~dRrW~~~~~~ 284 (339)
.||.+.|.+.+.++|.-. .=.||=||=+ .|=+||||-|=....|+|.=+.-++-..+-.
T Consensus 40 aai~~li~e~IP~DP~~~-------~yrqG~TLG~~~khW~RaKf~~ryRLFFRy~s~skiIv~aWvNDe~tlR~yg--- 109 (140)
T PF11663_consen 40 AAISKLIFEVIPADPTRP-------EYRQGNTLGDEYKHWFRAKFFQRYRLFFRYDSESKIIVYAWVNDEQTLRAYG--- 109 (140)
T ss_pred HHHHHHHHhhccCCCCch-------HhhCCCCCcccccchhhhcccceeeEEEEecCccCEEEEEEeCCCcchhhhc---
Confidence 488888888888876431 1258888843 3457999999999999999887666665542
Q ss_pred ccccccccchhHHHHhcCCCC
Q psy10618 285 ISKSHCSCDKNFKSCLKSTKS 305 (339)
Q Consensus 285 ~~~s~C~cd~~F~~CLk~~~~ 305 (339)
|.-+|=.+|+.=|++.+-
T Consensus 110 ---sk~DaY~VF~kML~~G~p 127 (140)
T PF11663_consen 110 ---SKTDAYAVFRKMLERGNP 127 (140)
T ss_pred ---cCCcHHHHHHHHHhCCCC
Confidence 355666999999977654
No 47
>PF02576 DUF150: Uncharacterised BCR, YhbC family COG0779; InterPro: IPR003728 The RimP protein facilitates maturation of the 30S ribsomal subunit, and is required for the efficient production of translationally competent ribosmomes [].; PDB: 1IB8_A.
Probab=38.42 E-value=26 Score=30.29 Aligned_cols=43 Identities=33% Similarity=0.415 Sum_probs=28.6
Q ss_pred HHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCC
Q psy10618 216 QAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVA 264 (339)
Q Consensus 216 ~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n 264 (339)
..+.|+++..|... .+.+-.-.+.||+-|+ .|.|..+|||..+
T Consensus 43 ~~~sr~i~~~LD~~-d~i~~~y~LEVSSPG~-----~r~L~~~~~~~~~ 85 (141)
T PF02576_consen 43 EKVSRAISALLDAE-DPIPEDYTLEVSSPGI-----DRPLKSPRDFERF 85 (141)
T ss_dssp HHHHHHHGGGTTTS-----S-EEEEEE--SS-----SS--SSHHHHHHH
T ss_pred HHHHHHHHHHHccc-cccCcceEEEEeCCCC-----CCcCCCHHHHHHh
Confidence 47789999999763 3457789999999998 7999999999754
No 48
>cd04706 PLA2_plant PLA2_plant: Plant-specific sub-family of Phospholipase A2, a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers. This sub-family does not appear to have a conserved active site and metal-binding loop.
Probab=34.31 E-value=18 Score=31.48 Aligned_cols=21 Identities=24% Similarity=0.642 Sum_probs=18.3
Q ss_pred cccccccchhHHHHhcCCCCh
Q psy10618 286 SKSHCSCDKNFKSCLKSTKSA 306 (339)
Q Consensus 286 ~~s~C~cd~~F~~CLk~~~~~ 306 (339)
.+.+|+|+..|..||++..++
T Consensus 61 ~~~~c~C~~~f~~Cl~~~~~~ 81 (117)
T cd04706 61 DYLSLECNEKFKNCVRRFRKA 81 (117)
T ss_pred CcCCchHHHHHHHHHHHhccc
Confidence 357999999999999888776
No 49
>cd07158 NR_DBD_Ppar_like The DNA-binding domain of peroxisome proliferator-activated receptors (PPAR) like nuclear receptor family. The DNA-binding domain of peroxisome proliferator-activated receptors (PPAR) like nuclear receptor family is composed of two C4-type zinc fingers. Each zinc finger contains a group of four Cys residues which co-ordinates a single zinc atom. These domains interact with specific DNA sites upstream of the target gene and modulate the rate of transcriptional initiation. This family includes three known types of nuclear receptors: peroxisome proliferator-activated receptors (PPAR), REV-ERB receptors and Drosophila ecdysone-induced protein 78 (E78). Like other members of the nuclear receptor (NR) superfamily of ligand-activated transcription factors, PPAR-like receptors have a central well conserved DNA binding domain (DBD), a variable N-terminal domain, a non-conserved hinge and a C-terminal ligand binding domain (LBD).
Probab=32.43 E-value=22 Score=27.68 Aligned_cols=15 Identities=27% Similarity=0.279 Sum_probs=11.1
Q ss_pred cccccccccccCCCc
Q psy10618 251 NKRQLFFRRHYPVAS 265 (339)
Q Consensus 251 nqRKlFFRRHYp~n~ 265 (339)
+.=|.||||+...+.
T Consensus 19 ~aC~~FFRR~v~~~~ 33 (73)
T cd07158 19 EGCKGFFRRTIQHNL 33 (73)
T ss_pred hHHHHHHhhhhcCCC
Confidence 556889999886553
No 50
>PRK14630 hypothetical protein; Provisional
Probab=29.46 E-value=46 Score=29.47 Aligned_cols=41 Identities=15% Similarity=0.245 Sum_probs=33.2
Q ss_pred HHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCC
Q psy10618 216 QAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVA 264 (339)
Q Consensus 216 ~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n 264 (339)
.++.|++...|.. |.+-.-++.||+-|+ .|.|+-.+||--+
T Consensus 55 ~~vSr~i~~~ld~---~i~~~Y~LEVSSPGl-----dRpL~~~~df~r~ 95 (143)
T PRK14630 55 CDLHKMILLILEA---VLKYNFSLEISTPGI-----NRKIKSDREFKIF 95 (143)
T ss_pred HHHHHHHHHHhcc---cCCCCeEEEEeCCCC-----CCcCCCHHHHHHh
Confidence 5888999999853 455668999999997 7999998988643
No 51
>PF13786 DUF4179: Domain of unknown function (DUF4179); PDB: 3FBQ_A.
Probab=29.20 E-value=49 Score=25.91 Aligned_cols=17 Identities=35% Similarity=0.427 Sum_probs=15.3
Q ss_pred CceEEEEEEecceeeee
Q psy10618 233 HAAVVHFKVSSQGITLT 249 (339)
Q Consensus 233 ~~tvVhFKVS~qGITLT 249 (339)
-.+.|+-.|+.+|||+|
T Consensus 57 ~~~~v~~s~t~~GitvT 73 (94)
T PF13786_consen 57 YSQEVNKSVTDNGITVT 73 (94)
T ss_dssp HSEEEEEEEEETTEEEE
T ss_pred cccccCcEEEECCEEEE
Confidence 46789999999999998
No 52
>PRK14634 hypothetical protein; Provisional
Probab=25.52 E-value=66 Score=28.80 Aligned_cols=43 Identities=16% Similarity=0.207 Sum_probs=34.9
Q ss_pred HHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCC
Q psy10618 216 QAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVA 264 (339)
Q Consensus 216 ~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n 264 (339)
.++.++++..|.... |.+---++.||+-|+ .|.|+-.|||--+
T Consensus 56 ~~vSr~is~~LD~~d-~i~~~Y~LEVSSPGl-----dRpL~~~~~f~r~ 98 (155)
T PRK14634 56 AGFSGPMGEALEASQ-LLTEAYVLEISSPGI-----GDQLSSDRDFQTF 98 (155)
T ss_pred HHHHHHHHHHhcccc-cCCCCeEEEEeCCCC-----CCcCCCHHHHHHh
Confidence 579999999997543 456678999999997 7999988888644
No 53
>PRK14647 hypothetical protein; Provisional
Probab=25.43 E-value=63 Score=28.91 Aligned_cols=43 Identities=21% Similarity=0.277 Sum_probs=34.5
Q ss_pred HHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCC
Q psy10618 216 QAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVA 264 (339)
Q Consensus 216 ~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n 264 (339)
.++.++++..|.... |.+---++.||+-|| .|.|+-.|||--+
T Consensus 55 ~~vSr~is~~LD~~d-~i~~~Y~LEVSSPG~-----~RpL~~~~~f~r~ 97 (159)
T PRK14647 55 AEVSRELSEILDVED-FIPERYTLEVSSPGL-----DRPLKKEADYERY 97 (159)
T ss_pred HHHHHHHHHHHcccc-cCCCCeEEEEcCCCC-----CCcCCCHHHHHHh
Confidence 588999999998543 345667999999997 7999988888644
No 54
>PF00712 DNA_pol3_beta: DNA polymerase III beta subunit, N-terminal domain; InterPro: IPR022634 This entry describes the N-terminal domain of the beta chain of DNA polymerase III. This is a complex, multichain enzyme responsible for most of the replicative synthesis in bacteria. The beta chain is required for initiation of replication from an RNA primer, nucleotide triphosphate (dNTP) residues being added to the 5'-end of the growing DNA chain.; GO: 0003677 DNA binding, 0003887 DNA-directed DNA polymerase activity, 0008408 3'-5' exonuclease activity, 0006260 DNA replication, 0009360 DNA polymerase III complex; PDB: 3P16_A 3RB9_B 2AWA_C 1VPK_A 2XUR_B 3Q4K_A 3BEP_A 3D1G_A 1UNN_B 3Q4J_D ....
Probab=24.76 E-value=91 Score=25.83 Aligned_cols=72 Identities=13% Similarity=0.122 Sum_probs=52.0
Q ss_pred HHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCCceeeecCCCCCCccccCCccccccccccchhH
Q psy10618 217 AVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPEDSRCLTRPWCISKSHCSCDKNF 296 (339)
Q Consensus 217 Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~dRrW~~~~~~~~~s~C~cd~~F 296 (339)
|++++..-+-..++.|.-.-|.|++..++++||=..-.+.++...|+... ...|. -.--.+.|
T Consensus 13 ~l~~v~~~i~~k~~~piL~~ili~a~~~~l~l~atD~e~~i~~~i~~~~~------------~~~G~-----~~v~ak~l 75 (120)
T PF00712_consen 13 ALSKVSKVIPSKSTIPILSNILIEAKDNKLTLTATDLEISIRTTIPAEIE------------EEEGS-----ILVPAKKL 75 (120)
T ss_dssp HHHHHHTCSSSSSSSGGGGEEEEEEETTEEEEEEE-SSEEEEEEEETEEE------------EE-EE-----EEEEHHHH
T ss_pred HHHHHHhhhCCCCChHHhccEEEEEeCCEEEEEEEcCeEEEEEEEeceee------------cCCeE-----EEEEhHHH
Confidence 45554444445677788889999999999999988888999999998876 22222 12335789
Q ss_pred HHHhcCCCC
Q psy10618 297 KSCLKSTKS 305 (339)
Q Consensus 297 ~~CLk~~~~ 305 (339)
..-+|+..+
T Consensus 76 ~~ivk~lp~ 84 (120)
T PF00712_consen 76 FDIVKKLPD 84 (120)
T ss_dssp HHHHHHSSS
T ss_pred HHHHHhCCC
Confidence 999988777
No 55
>KOG0197|consensus
Probab=24.68 E-value=24 Score=37.16 Aligned_cols=52 Identities=31% Similarity=0.232 Sum_probs=44.3
Q ss_pred hhhhhhccccCCCCceeccCCCCCCCCchhhheeccccccccccccccCCCC
Q psy10618 122 ELVRHFLIEPTPRGVRLKGCSNEPVFSSLSALVYQHSVLPLALPCRLSLPDS 173 (339)
Q Consensus 122 ~lvrHfLIe~~~~gv~lkGc~~Ep~F~Slsalv~qhsi~~laLPC~L~iP~~ 173 (339)
..|+|+-|...+.|-..--+...-.|+++..||.+|+.+...|..+|.-|..
T Consensus 133 ~~v~hyri~~~~~~~~~~~~~~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~ 184 (468)
T KOG0197|consen 133 AKVKHYRIRQLDGGGLYPYIDERELFSSLQQLVNYYSKNADGLCTRLRDPCS 184 (468)
T ss_pred cceeeeeeeEcCCCCeecCCCHHHhhhhHHHHHhhhhccCcchhhcccCchh
Confidence 4799999999988877766777779999999999999999888877777754
No 56
>cd07157 2DBD_NR_DBD1 The first DNA-binding domain (DBD) of the 2DBD nuclear receptors is composed of two C4-type zinc fingers. The first DNA-binding domain (DBD) of the 2DBD nuclear receptors(NRs) is composed of two C4-type zinc fingers. Each zinc finger contains a group of four Cys residues which co-ordinates a single zinc atom. NRs interact with specific DNA sites upstream of the target gene and modulate the rate of transcriptional initiation. Theses proteins contain two DBDs in tandem, probably resulted from an ancient recombination event. The 2DBD-NRs are found only in flatworm species, mollusks and arthropods. Their biological function is unknown.
Probab=24.55 E-value=47 Score=26.90 Aligned_cols=16 Identities=25% Similarity=0.210 Sum_probs=12.0
Q ss_pred ccccccccccccCCCc
Q psy10618 250 DNKRQLFFRRHYPVAS 265 (339)
Q Consensus 250 DnqRKlFFRRHYp~n~ 265 (339)
=+.=|.||||+...+.
T Consensus 20 C~aCk~FFRR~~~~~~ 35 (86)
T cd07157 20 CEACKKFFMRSSNAIS 35 (86)
T ss_pred eeEeeeEEecceecCC
Confidence 3566889999887654
No 57
>cd07166 NR_DBD_REV_ERB DNA-binding domain of REV-ERB receptor-like is composed of two C4-type zinc fingers. DNA-binding domain of REV-ERB receptor- like is composed of two C4-type zinc fingers. Each zinc finger contains a group of four Cys residues which coordinates a single zinc atom. This domain interacts with specific DNA sites upstream of the target gene and modulates the rate of transcriptional initiation. REV-ERB receptors are transcriptional regulators belonging to the nuclear receptor superfamily. They regulate a number of physiological functions including the circadian rhythm, lipid metabolism, and cellular differentiation. REV-ERB receptors bind as a monomer to a (A/G)GGTCA half-site with a 5' AT-rich extension or as a homodimer to a direct repeat 2 element (AGGTCA sequence with a 2-bp spacer), indicating functional diversity. When bound to the DNA, they recruit corepressors (NcoR/histone deacetylase 3) to the promoter, resulting in repression of the target genes. The porphyr
Probab=24.12 E-value=36 Score=27.78 Aligned_cols=46 Identities=24% Similarity=0.414 Sum_probs=24.2
Q ss_pred cccccccccccCCCcee-eecCCCCCCccccCCccccccccccchhHHHHhcC
Q psy10618 251 NKRQLFFRRHYPVASIS-YCGLDPEDSRCLTRPWCISKSHCSCDKNFKSCLKS 302 (339)
Q Consensus 251 nqRKlFFRRHYp~n~v~-fC~lDP~dRrW~~~~~~~~~s~C~cd~~F~~CLk~ 302 (339)
+.=|.||||+...+... -|..+.+ --. ...++..|.- -+|..||..
T Consensus 24 ~aCk~FFRR~v~~~~~~~~C~~~~~--C~i---~~~~r~~Cr~-CRl~KCl~v 70 (89)
T cd07166 24 EGCKGFFRRSIQQKIQYRKCTKNET--CSI---MRINRNRCQY-CRFKKCLAV 70 (89)
T ss_pred hhHhhEecceeEcCCcchhhccCCc--ccc---cccccccccc-hhhhhcccc
Confidence 55688999998666433 2543211 000 0112333432 489999964
No 58
>cd06960 NR_DBD_HNF4A DNA-binding domain of heptocyte nuclear factor 4 (HNF4) is composed of two C4-type zinc fingers. DNA-binding domain of hepatocyte nuclear factor 4 (HNF4) is composed of two C4-type zinc fingers. Each zinc finger contains a group of four Cys residues which co-ordinates a single zinc atom. HNF4 interacts with a DNA site, composed of two direct repeats of AGTTCA with 1 bp spacer, which is upstream of target genes and modulates the rate of transcriptional initiation. HNF4 is a member of the nuclear receptor superfamily. HNF4 plays a key role in establishing and maintenance of hepatocyte differentiation in the liver. It is also expressed in gut, kidney, and pancreatic beta cells. HNF4 was originally classified as an orphan receptor, but later it is found that HNF4 binds with very high affinity to a variety of fatty acids. However, unlike other nuclear receptors, the ligands do not act as a molecular switch for HNF4. They seem to constantly bind to the receptor, which is
Probab=24.08 E-value=54 Score=25.66 Aligned_cols=47 Identities=23% Similarity=0.327 Sum_probs=26.8
Q ss_pred ccccccccccccCCCceeeecCCCCCCccccCCccccccccccchhHHHHhcC
Q psy10618 250 DNKRQLFFRRHYPVASISYCGLDPEDSRCLTRPWCISKSHCSCDKNFKSCLKS 302 (339)
Q Consensus 250 DnqRKlFFRRHYp~n~v~fC~lDP~dRrW~~~~~~~~~s~C~cd~~F~~CLk~ 302 (339)
=+.=|.||||+...+...-|.-+.+ - .. ...++..|.- -+|..||..
T Consensus 18 C~aC~~FFrR~~~~~~~~~C~~~~~--C-~i--~~~~r~~C~~-CR~~KCl~v 64 (76)
T cd06960 18 CNGCKGFFRRSVRKNRTYTCRFGGN--C-VV--DKDKRNACRY-CRFKKCLEV 64 (76)
T ss_pred eeeehheeCccccCCCceeCCCCCc--c-cc--cCcccccCcc-chhhhhhhc
Confidence 3566889999998776666654311 0 00 0112334432 379999965
No 59
>KOG4278|consensus
Probab=23.59 E-value=26 Score=39.15 Aligned_cols=49 Identities=29% Similarity=0.360 Sum_probs=38.4
Q ss_pred hhhhhhccccCCCCceeccCCCCCCCCchhhheeccccccccccccccCCC
Q psy10618 122 ELVRHFLIEPTPRGVRLKGCSNEPVFSSLSALVYQHSVLPLALPCRLSLPD 172 (339)
Q Consensus 122 ~lvrHfLIe~~~~gv~lkGc~~Ep~F~Slsalv~qhsi~~laLPC~L~iP~ 172 (339)
.-|-|+-|.....|-..-. .|--|.+|..||||||.-+=.|=|.|+-|.
T Consensus 196 GRVyHYRINt~~dgK~yvt--~EsrF~TLaELVHHHStvADGLittLhYPA 244 (1157)
T KOG4278|consen 196 GRVYHYRINTDNDGKMYVT--QESRFRTLAELVHHHSTVADGLITTLHYPA 244 (1157)
T ss_pred ceEEEEEeeccCCccEEEe--ehhhhhHHHHHHhhccccccceeEeeeccC
Confidence 4567888877666544433 466799999999999999999999999984
No 60
>cd06916 NR_DBD_like DNA-binding domain of nuclear receptors is composed of two C4-type zinc fingers. DNA-binding domain of nuclear receptors is composed of two C4-type zinc fingers. Each zinc finger contains a group of four Cys residues which co-ordinates a single zinc atom. It interacts with a specific DNA site upstream of the target gene and modulates the rate of transcriptional initiation. Nuclear receptors form a superfamily of ligand-activated transcription regulators, which regulate various physiological functions, from development, reproduction, to homeostasis and metabolism in animals (metazoans). The family contains not only receptors for known ligands but also orphan receptors for which ligands do not exist or have not been identified. NRs share a common structural organization with a central well conserved DNA binding domain (DBD), a variable N-terminal domain, a flexible hinge and a C-terminal ligand binding domain (LBD). Most nuclear receptors bind as homodimers or hetero
Probab=23.53 E-value=52 Score=25.55 Aligned_cols=47 Identities=19% Similarity=0.194 Sum_probs=25.5
Q ss_pred ccccccccccccCCCceeeecCCCCCCccccCCccccccccccchhHHHHhcC
Q psy10618 250 DNKRQLFFRRHYPVASISYCGLDPEDSRCLTRPWCISKSHCSCDKNFKSCLKS 302 (339)
Q Consensus 250 DnqRKlFFRRHYp~n~v~fC~lDP~dRrW~~~~~~~~~s~C~cd~~F~~CLk~ 302 (339)
=+.=|.||||+...+...-|.-+.+=.. ...++..|.- -+|..||..
T Consensus 18 C~aC~~FFRR~~~~~~~~~C~~~~~C~i-----~~~~r~~C~~-CR~~KCl~v 64 (72)
T cd06916 18 CEGCKGFFRRSVRRNLEYTCPAGGNCVI-----DKRNRNRCQA-CRLKKCLAV 64 (72)
T ss_pred eeeeeeeEeEeecCCCCccCCCCCcccc-----CCcccccCcc-chhhHhhHh
Confidence 3566889999887665555543211000 0112334432 379999964
No 61
>cd06965 NR_DBD_Ppar DNA-binding domain of peroxisome proliferator-activated receptors (PPAR) is composed of two C4-type zinc fingers. DNA-binding domain of peroxisome proliferator-activated receptors (PPAR) is composed of two C4-type zinc fingers. Each zinc finger contains a group of four Cys residues which co-ordinates a single zinc atom. PPAR interacts with specific DNA sites upstream of the target gene and modulates the rate of transcriptional initiation. Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor superfamily of ligand-activated transcription factors. PPARs play important roles in regulating cellular differentiation, development and lipid metabolism. Activated PPAR forms a heterodimer with the retinoid X receptor (RXR) that binds to the hormone response elements, which are composed of two direct repeats of the consensus sequence 5'-AGGTCA-3' separated by one to five base pair located upstream of the peroxisome proliferator responsive gene
Probab=21.98 E-value=46 Score=26.81 Aligned_cols=41 Identities=22% Similarity=0.512 Sum_probs=23.6
Q ss_pred ccccccccccccCCCceee-e----cCCCCCCccccCCccccccccccchhHHHHhcC
Q psy10618 250 DNKRQLFFRRHYPVASISY-C----GLDPEDSRCLTRPWCISKSHCSCDKNFKSCLKS 302 (339)
Q Consensus 250 DnqRKlFFRRHYp~n~v~f-C----~lDP~dRrW~~~~~~~~~s~C~cd~~F~~CLk~ 302 (339)
=+.=|.||||+...+...- | .+|... +..|.- -+|..||..
T Consensus 19 C~aCk~FFRR~v~~~~~~~~C~~~C~i~~~~-----------r~~Cr~-CRl~KCl~v 64 (84)
T cd06965 19 CEGCKGFFRRTIRLKLVYKPCDLSCKIHKKS-----------RNKCQY-CRFQKCLNV 64 (84)
T ss_pred hhhhhhheeeeeecCCCccccccCCCcCccc-----------cccccc-hhhhhhhhc
Confidence 3566889999886553321 4 333322 233432 389999964
No 62
>PRK14645 hypothetical protein; Provisional
Probab=21.04 E-value=94 Score=27.94 Aligned_cols=43 Identities=28% Similarity=0.420 Sum_probs=34.1
Q ss_pred HHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCC
Q psy10618 216 QAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVA 264 (339)
Q Consensus 216 ~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n 264 (339)
.++.++++..|.... |.+---.+.||+-|| .|.|+-.|||--+
T Consensus 58 ~~vSr~is~~LD~~d-~i~~~Y~LEVSSPGl-----dRpL~~~~df~r~ 100 (154)
T PRK14645 58 ERASRALEAELDRLD-PIEGEYRLEVESPGP-----KRPLFTARHFERF 100 (154)
T ss_pred HHHHHHHHHHhcccc-cCCCceEEEEeCCCC-----CCCCCCHHHHHHh
Confidence 579999999997543 345667899999997 7999888888643
No 63
>cd07168 NR_DBD_DHR4_like DNA-binding domain of ecdysone-induced DHR4 orphan nuclear receptor is composed of two C4-type zinc fingers. DNA-binding domain of ecdysone-induced DHR4 orphan nuclear receptor is composed of two C4-type zinc fingers. Each zinc finger contains a group of four Cys residues which coordinates a single zinc atom. This domain interacts with specific DNA sites upstream of the target gene and modulates the rate of transcriptional initiation. Ecdysone-induced orphan receptor DHR4 is a member of the nuclear receptor family. DHR4 is expressed during the early Drosophila larval development and is induced by ecdysone. DHR4 coordinates growth and maturation in Drosophila by mediating endocrine response to the attainment of proper body size during larval development. Mutations in DHR4 result in shorter larval development which translates into smaller and lighter flies. Like other members of the nuclear receptor (NR) superfamily of ligand-activated transcription factors, DHR4
Probab=20.95 E-value=45 Score=27.26 Aligned_cols=56 Identities=18% Similarity=0.331 Sum_probs=30.8
Q ss_pred eEEEEEEecceeeeeccccccccccccCCCceeeecCCCCCCccccCCccccccccccchhHHHHhcC
Q psy10618 235 AVVHFKVSSQGITLTDNKRQLFFRRHYPVASISYCGLDPEDSRCLTRPWCISKSHCSCDKNFKSCLKS 302 (339)
Q Consensus 235 tvVhFKVS~qGITLTDnqRKlFFRRHYp~n~v~fC~lDP~dRrW~~~~~~~~~s~C~cd~~F~~CLk~ 302 (339)
+..||-|. +=+.=|.||||+...+...-|.-+-+ - .. ...++..|.- -+|..||..
T Consensus 17 ~g~hyGv~------sC~aCk~FFRR~v~~~~~~~C~~~~~--C-~i--~~~~r~~Cr~-CR~~KCl~v 72 (90)
T cd07168 17 TGLHYGII------TCEGCKGFFKRTVQNKRVYTCVGDGR--C-EI--TKAQRNRCQY-CRFRKCIRK 72 (90)
T ss_pred cceEECce------ehhhhhHhhhhhhcCCCCccCCCCCC--c-cc--cccccccccc-cchhhhhhc
Confidence 34677653 44677899999987766555542111 0 00 0112233432 389999964
No 64
>PRK14643 hypothetical protein; Provisional
Probab=20.45 E-value=91 Score=28.31 Aligned_cols=43 Identities=14% Similarity=0.171 Sum_probs=34.7
Q ss_pred HHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCC
Q psy10618 216 QAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVA 264 (339)
Q Consensus 216 ~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n 264 (339)
.++.++++..|... -|.+..-.+.||+-|| .|.|+-.+||-.+
T Consensus 60 ~~vSr~is~~LD~~-d~i~~~Y~LEVSSPGl-----eRpL~~~~df~r~ 102 (164)
T PRK14643 60 IKANDLVSNKIDQF-IKTSEKYLLEISSSGI-----EKQIRSQEELVKA 102 (164)
T ss_pred HHHHHHHHHHhCcc-CCCCCCeEEEecCCCC-----CCCCCCHHHHHHh
Confidence 47889999999754 3467788999999997 7999988888543
No 65
>TIGR03330 SAM_DCase_Bsu S-adenosylmethionine decarboxylase proenzyme, Bacillus form. Members of this protein family are the single chain precursor of the two chains of the mature S-adenosylmethionine decarboxylase as found in Methanocaldococcus jannaschii, Bacillus subtilis, and a wide range of other species. It differs substantially in architecture from the form as found in Escherichia coli, and lacks any extended homology to the eukaryotic form (TIGR00535).
Probab=20.36 E-value=1.1e+02 Score=25.94 Aligned_cols=46 Identities=17% Similarity=0.129 Sum_probs=32.8
Q ss_pred eeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEecceeeee
Q psy10618 204 LVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLT 249 (339)
Q Consensus 204 L~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLT 249 (339)
|+.++.+-|.-+.+|++++.+.........-.+..-+-+.||||.+
T Consensus 11 ly~c~~~~L~d~~~l~~~l~~a~~~~g~ti~~~~~h~F~p~Gvt~v 56 (112)
T TIGR03330 11 LYGCDPEKLDDVEFIEEILLEAAKVAGATLVASHFHKFSPGGVSGV 56 (112)
T ss_pred EeCCChHHCCCHHHHHHHHHHHHHHcCCEEEEEEEEEcCCCcEEEE
Confidence 5557888899999999999998876544333333344557898876
No 66
>PRK14640 hypothetical protein; Provisional
Probab=20.31 E-value=97 Score=27.58 Aligned_cols=43 Identities=21% Similarity=0.371 Sum_probs=34.6
Q ss_pred HHHHHHHHhhhCCCCCCCceEEEEEEecceeeeeccccccccccccCCC
Q psy10618 216 QAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLTDNKRQLFFRRHYPVA 264 (339)
Q Consensus 216 ~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLTDnqRKlFFRRHYp~n 264 (339)
.++.+|++..|.... |.+---.+.||+-|| .|.|+-.|||--+
T Consensus 53 ~~vSr~is~~LD~~d-~i~~~Y~LEVSSPGl-----~RpL~~~~~f~r~ 95 (152)
T PRK14640 53 AEVSHQVGAIMDVED-PITEEYYLEVSSPGL-----DRPLFKVAQFEKY 95 (152)
T ss_pred HHHHHHHHHHhcccc-cCCCCeEEEEeCCCC-----CCcCCCHHHHHHh
Confidence 588999999998643 456668999999997 7999888888643
No 67
>PF02675 AdoMet_dc: S-adenosylmethionine decarboxylase ; InterPro: IPR003826 Polyamines such as spermidine and spermine are essential for cellular growth under most conditions, being implicated in a large number of cellular processes including DNA, RNA and protein synthesis. S-adenosylmethionine decarboxylase (AdoMetDC) plays an essential regulatory role in the polyamine biosynthetic pathway by generating the n-propylamine residue required for the synthesis of spermidine and spermine from putrescein [, ]. Unlike many amino acid decarboxylases AdoMetDC uses a covalently bound pyruvate residue as a cofactor rather than the more common pyridoxal 5'-phosphate. These proteins can be divided into two main groups which show little sequence similarity either to each other, or to other pyruvoyl-dependent amino acid decarboxylases: class I enzymes found in bacteria and archaea, and class II enzymes found in eukaryotes. In both groups the active enzyme is generated by the post-translational autocatalytic cleavage of a precursor protein. This cleavage generates the pyruvate precursor from an internal serine residue and results in the formation of two non-identical subunits termed alpha and beta which form the active enzyme. Members of this family are related to the amino terminus of Escherichia coli S-adenosylmethionine decarboxylase.; GO: 0004014 adenosylmethionine decarboxylase activity, 0008295 spermidine biosynthetic process; PDB: 1VR7_A 3IWC_D 3IWD_D 3IWB_C 1TMI_A 1TLU_A 2III_A.
Probab=20.05 E-value=77 Score=26.15 Aligned_cols=46 Identities=20% Similarity=0.271 Sum_probs=29.6
Q ss_pred eeeeccCCccchHHHHHHHHhhhCCCCCCCceEEEEEEecceeeee
Q psy10618 204 LVSVDTESLTGPQAVTRAINSLFGTKPLPHAAVVHFKVSSQGITLT 249 (339)
Q Consensus 204 L~sv~~esltG~~Av~kAv~~~l~~~~~p~~tvVhFKVS~qGITLT 249 (339)
+..++.+.|.-++++++++.+.+..-....-.+...+-+.||+|.+
T Consensus 6 ~~~c~~~~L~d~~~l~~~l~~a~~~~g~~~~~~~~~~f~p~GvT~~ 51 (106)
T PF02675_consen 6 LYGCDPDLLNDAEALEKILRDAAKAAGLTVLSISFHKFEPQGVTGV 51 (106)
T ss_dssp EES--HHHCTSHHHHHHHHHHHHHHCT-EEEEEEEEE-SSS-EEEE
T ss_pred EECCChHHCCCHHHHHHHHHHHHHHcCCEEEEEEEEEcCCCcEEEE
Confidence 4456777888999999999999876544333334455567999976
Done!